August 6, 2021Free Activators

August 6, 2021Free Activators

August 6, 2021Free Activators

Abstract Methylaluminoxane (MAO) activators have sheet structures which form ion-pairs on reaction of neutral donors First published: 26 August After installation, you will need to activate Office , this is necessary in On this page are free working ways to activate it. August 10, A tribute to Eddy Fischer (April 6, –August 27, ): Join for free against dissociation, while activators like valine or. August 6, 2021Free Activators

watch the video

24 Oras Livestream: August 6, 2021 - Replay

August 6, 2021Free Activators - sorry

Objective

Metabolic syndrome (MetS) is defined as a complex of interrelated risk factors for type 2 diabetes and cardiovascular disease, including glucose intolerance, abdominal obesity, hypertension, and dyslipidemia. Studies using diffusion tensor imaging (DTI) have reported white matter (WM) microstructural abnormalities in MetS. However, interpretation of DTI metrics is limited primarily due to the challenges of modeling complex WM structures. The present study used fixel-based analysis (FBA) to assess the effect of MetS on the fiber tract-specific WM microstructure in older adults and its relationship with MetS-related measurements and cognitive and locomotor functions to better understand the pathophysiology of MetS.

Methods

Fixel-based metrics, including microstructural fiber density (FD), macrostructural fiber-bundle cross-section (FC), and a combination of FD and FC (FDC), were evaluated in 16 healthy controls (no components of MetS; four men; mean age,  ±  years), 57 individuals with premetabolic syndrome (preMetS; one or two components of MetS; 29 men; mean age,  ±  years), and 46 individuals with MetS (three to five components of MetS; 27 men; mean age,  ±  years) using whole-brain exploratory FBA. Tract of interest (TOI) analysis was then performed using TractSeg across 14 selected WM tracts previously associated with MetS. The associations between fixel-based metrics and MetS-related measurements, neuropsychological, and locomotor function tests were also analyzed in individuals with preMetS and MetS combined. In addition, tensor-based metrics (i.e., fractional anisotropy [FA] and mean diffusivity [MD]) were compared among the groups using tract-based spatial statistics (TBSS) analysis.

Results

In whole-brain FBA, individuals with MetS showed significantly lower FD, FC, and FDC compared with healthy controls in WM areas, such as the splenium of the corpus callosum (CC), corticospinal tract (CST), middle cerebellar peduncle (MCP), and superior cerebellar peduncle (SCP). Meanwhile, in fixel-based TOI, significantly reduced FD was observed in individuals with preMetS and MetS in the anterior thalamic radiation, CST, SCP, and splenium of the CC compared with healthy controls, with relatively greater effect sizes observed in individuals with MetS. Compared with healthy controls, significantly reduced FC and FDC were only demonstrated in individuals with MetS, including regions with loss of FD, inferior cerebellar peduncle, inferior fronto-occipital fasciculus, MCP, and superior longitudinal fasciculus part I. Furthermore, negative correlations were observed between FD and Brinkman index of cigarette consumption cumulative amount and between FC or FDC and the Trail Making Test (parts B–A), which is a measure of executive function, waist circumference, or low-density lipoprotein cholesterol. Finally, TBSS analysis revealed that FA and MD were not significantly different among all groups.

Conclusions

The FBA results demonstrate that substantial axonal loss and atrophy in individuals with MetS and early axonal loss without fiber-bundle morphological changes in those with preMetS within the WM tracts are crucial to cognitive and motor function. FBA also clarified the association between executive dysfunction, abdominal obesity, hyper-low-density lipoprotein cholesterolemia, smoking habit, and compromised WM neural tissue microstructure in MetS.

Journal Article

Abstract

The new generation of cell-free gene expression systems enables the prototyping and engineering of biological systems in vitro over a remarkable scope of applications and physical scales. As the utilization of DNA-directed in vitro protein synthesis expands in scope, developing more powerful cell-free transcription–translation (TXTL) platforms remains a major goal to either execute larger DNA programs or improve cell-free biomanufacturing capabilities. In this work, we report the capabilities of the all-E. coli TXTL toolbox , a multipurpose cell-free expression system specifically developed for synthetic biology. In non-fed batch-mode reactions, the synthesis of the fluorescent reporter protein eGFP (enhanced green fluorescent protein) reaches 4 mg/ml. In synthetic cells, consisting of liposomes loaded with a TXTL reaction, eGFP is produced at concentrations of >8 mg/ml when the chemical building blocks feeding the reaction diffuse through membrane channels to facilitate exchanges with the outer solution. The bacteriophage T7, encoded by a genome of 40 kb and ∼60 genes, is produced at a concentration of 1013 PFU/ml (plaque forming unit/ml). This TXTL system extends the current cell-free expression capabilities by offering unique strength and properties, for testing regulatory elements and circuits, biomanufacturing biologics or building synthetic cells.

1. Introduction

The emerging enthusiasm for cell-free gene expression as a multipurpose bioengineering technology arises from several major improvements made in the last two decades. These advances have been predominantly made for cell-free expression systems from Escherichia coli, the most common model organism (1–5). First, cell-free transcription–translation (TXTL: cell-free transcription–translation) systems have become powerful enough to enable executing genetic programs composed of several genes relevant to natural living systems (6, 7) and integrating new technologies like CRISPR (clustered regularly interspaced short palindromic repeats) (8–11). The current TXTL technology is characterized by a fast experimental turnover and high-throughput settings (12), which facilitates the rapid prototyping of regulatory elements and gene networks (13–22). Besides gene circuits, the strength of the current TXTL platforms is leveraged to develop new biomanufacturing methods that offer the unique speed of delivery and portability (23–27). Second, the preparation of TXTL systems, from E. coli especially, has been streamlined and reported in detail (28–30), which considerably improved the affordability and accessibility to these systems. Third, TXTL carries by nature a high degree of safety, making it ideal for applications outside laboratories, such as education (11, 31). Altogether, cell-free gene expression has been shaped into a versatile and user-friendly tool covering an ever-growing scope of applications (6, 7, 32–34). Although TXTL systems from a broad variety of organisms are being developed (35), the cell-free gene expression based on E. coli lysate remains the major test bed due to its strength and the knowledge of this system.

Among the different E. coli platforms developed, the all-E. coli TXTL system, now commercially available under the name myTXTL, was devised to incorporate a broad transcription repertoire that comprises the seven E. coli sigma factors in addition to the routinely used T7 and T3 bacteriophage ribonucleic acid (RNA) polymerases and promoters (36, 37). In its second version (38), a new adenosine triphosphate (ATP) regeneration was used to raise protein synthesis up to  mg/ml in batch mode (39). By means of its extensive transcription capabilities and its strength, this TXTL system has been employed in many different physical settings for synthetic biology purposes or to address fundamental questions (Figure 1). This system has proven effective for prototyping short deoxyribonucleic acid (DNA) (13–17) and gene circuits (18–20, 40, 41), biomanufacturing (38, 42–46) and building synthetic cells (38, 47–54). It is also a convenient platform to interrogate biological systems at a basic level, including reconstituting dynamical systems (19), emulating pattern formation (20, 40), showing decision-making based on a few molecules in regulatory networks (55) and revealing the importance of molecular crowding in two dimensions for the self-assembly of cytoskeletal proteins (49, 50).

Figure 1.

Overview of the all-E. coli TXTL system and its applications. References are given as examples of the toolbox usage.

In this article, we present the major capabilities of the new version of the all-E. coli TXTL toolbox, focusing on protein synthesis through the transcription repertoire, the synthesis of the phage T7 used as a reference for the processing of large DNA programs and protein synthesis in synthetic cell systems. Other characteristics of this toolbox have been reported in version (38) such as messenger RNA and protein degradation and are not discussed in this work. When appropriate, we highlight the main differences between the three versions of the system, toolbox published in (36), toolbox published in (38) and toolbox reported in this article.

2. Materials and methods

TXTL system and batch-mode reactions

The preparation of the cell-free expression system used in this work has been described thoroughly in several articles (28, 36, 38, 56). The toolbox (38) is commercialized under the name myTXTL (Arbor Biosciences). Compared to the toolbox (38), two major modifications were made. First, the cells (E. coli strain BL21 Rosetta2, Millipore Sigma) were grown at 40°C instead of 37°C during lysate preparation. Second, cell-free reactions were supplemented with 60 mM maltodextrin (Sigma Aldrich ) and 30 mM d-ribose (Sigma Aldrich R) instead of just maltodextrin. Supplementary Table S1 summarizes the references that describe, in detail, the preparation of this system and the differences between the toolboxes versions. Cell-free reactions were carried out in a volume of 2–20 µl at 29–30°C. The reactions were either assembled by hand (10–20 µl) or dispensed on well plates using a Beckman Labcyte Echo liquid dispenser (2–5 µl). Quantitative measurements were carried out with the reporter protein deGFP (d-enhanced green fluorescent protein) ( kDa, 1 mg/ml =  µM). deGFP is a variant of the reporter eGFP (enhanced green fluorescent protein) that is more translatable in cell-free systems. The excitation and emission spectra, as well as fluorescence properties of deGFP and eGFP, are identical, as reported before (36). The fluorescence of deGFP produced in batch-mode reaction was measured on an H1m plate reader (Biotek Instruments, well plate). Endpoint measurements were carried out after 15–20 h of incubation. Pure recombinant eGFP with a His tag (from either Cell Biolabs Inc. or Biovision) was used for quantification (linear calibration of the plate reader and microscope as described before (38)). Error bars are the standard deviations from at least three replicates.

DNA part lists and plasmid preparation

The DNA parts used in this work are available at Arbor Biosciences and are reported in Supplementary Table S2 (plasmids) and Supplementary Table S3 (linear). GenBank files of the plasmids used in this work are available as supplementary material. Unless specified, the plasmids contain the highly efficient untranslated region named UTR1 (36). The plasmids were amplified using standard mini or midi prep kits and further cleaned up with a polymerase chain reaction (PCR) purification kit and eluted in autoclaved water. The concentration of the DNA stock solutions was quantified on a NanoDrop spectrophotometer. Linear DNA templates were amplified by standard PCR from the respective plasmids, cleaned up using a PCR purification kit and eluted in autoclaved water. P70a-gamS was obtained from Twist Biosciences and amplified by PCR.

TXTL synthesis of phages

The T7 genomic DNA was purchased from Boca Scientific. The chi6 short DNA (Integrated DNA Technologies) was added at a concentration of 3 µM to prevent the degradation of the linear T7 DNA (57). dNTPs (deoxynucleotide triphosphates) (Invitrogen) were added to a concentration of  mM each to enable genome replication, as described before (44). The PEG (Sigma Aldrich) concentration was increased from 2% ( mM) to % ( mM) to emulate molecular crowding (43). Bacteriophages were counted by the standard plaque-forming assay using the E. coli strain B for T7. Cells were grown in Luria–Bertani (LB) broth at 37°C. The plates were prepared as follows: each sample was added to a solution composed of 5 ml of % liquid LB-agar (45°C) and 50 µl of cell culture, poured on a % solid LB-agar plate. Plates were incubated at 37°C, and plaques were counted after 6 h.

TXTL-based synthetic cells

The cell-free reactions were encapsulated into large unilamellar phospholipid vesicles by the water-in-oil emulsion transfer method (48). Briefly, phospholipids (Avanti Polar Lipids, PC , PE-PEG ) were dissolved in mineral oil (Sigma-Aldrich M) at a total concentration of 2 mg/ml (molar proportion: % PC and % PE-PEG). A few microliters of cell-free reaction was added to  ml of the phospholipid solution. This solution was vortexed for 5–10 s to create an emulsion. About – µl of the emulsion was placed on top of 20 µl of the feeding solution. The vesicles are formed by the centrifugation of the biphasic solution for 20 s at rpm. The phospholipid vesicles were observed with a CCD (charge-coupled device) camera mounted on an inverted microscope (Olympus IX) equipped with the proper set of fluorescence filters. The feeding solution contained the same components as the reaction except for the DNA and lysate that were replaced by water. Pure alpha-hemolysin (AH) was purchased from Sigma Aldrich.

Materials and resources availability statement

The list of plasmids used in this work (available at Arbor Biosciences) is summarized in Supplementary Table S2. The protocols for the Cell-Free Expression (CFE) system are available in the references provided and in Supplementary Table S1. Other materials are available on reasonable request.

3. Results and discussion

Overall picture of the all-E. coli TXTL system

To build a versatile toolbox that does not rely only on the T7 promoter and polymerase, our original goal was to develop an all-E. coli TXTL system that integrates a broad transcription repertoire so as to execute circuits composed of different regulatory elements. The primary transcription is achieved by the housekeeping sigma factor σ70 and the core RNA polymerase, both provided by the lysate, which also brings all the necessary components for translation. Transcription by the six other sigma factors and the two bacteriophage RNA polymerases T3 and T7 are performed via transcriptional activation cascades. The second goal was to achieve a protein synthesis level large enough to enable the expression of large genetic programs and biomanufacturing of biologics. To this end, the toolbox incorporates a chemical ATP regeneration based on a phosphate donor and a carbohydrate to exploit the glycolytic pathway of the lysate (38, 39). Several other functionalities were developed: (i) protein degradation via the ClpXP proteases (38), (ii) tunable messenger RNA degradation via the interferase MazF (58), (iii) protection of linear DNA templates such as PCR products via the GamS protein (28) and the chi6 short linear dsDNA (57). These functionalities, valid for the new version of the system reported here, have been already described thoroughly. Lysates are prepared on a regular basis and tested for leftovers of living E. coli cells by plating the equivalent of – µl of cell-free reaction on LB-agar petri dishes without antibiotics. As reported several times before, no colonies are observed when this control is done (Supplementary Figure S1), making it a true cell-free expression system.

Compared to the toolbox (38), the toolbox reported in this article incorporates two changes that enable protein synthesis >3 mg/ml. First, during the lysate preparation, the cells are grown at 40°C instead of 37°C. It was demonstrated previously that increasing the temperature of E. coli cultures can improve cell-free protein synthesis yields (59). The second modification applies to the reaction. Rather than just adding maltodextrin as a carbohydrate source to exploit glycolysis in the lysate (39), a mixture of maltodextrin (60 mM) and d-ribose (30 mM) is added to the reaction. We assume that maltodextrin and d-ribose improve ATP regeneration, but their role would need to be clarified by a study outside the scope of this work. It is the combination of these two changes (temperature and carbohydrate mixture) that enables cell-free protein synthesis to reach up to 4 mg/ml.

Protein synthesis yields and time course

We measured protein synthesis in batch mode for the seven E. coli transcription factors, the two bacteriophage RNA polymerases T3 and T7, and linear PCR products for both σ70 and T7, and we compared the results to the two previous versions of the toolbox (Table 1). Except for σ70 already present in the lysate, the synthesis of the reporter protein deGFP was achieved through a transcriptional activation cascade and specific promoters for each transcription factor or RNA polymerase. Each transcription factor or RNA polymerase was expressed through the strong E. coli promoter P70a and the untranslated region UTR1 (36), which originates from the bacteriophage T7 (60). The performance of all the sigma factors and bacteriophage RNA polymerases was largely greater than for the toolboxes and (Table 1). For toolbox , the maximum protein synthesis concentration was observed for the T7 cascade and topped 4 mg/ml. The effects of varying maltodextrin and d-ribose show the synergy produced by the two carbohydrates (Supplementary Figure S2). The effect of the temperature of cell growth cultures during the lysate preparation was measured in the case of the T7 cascade to show that a temperature of 40°C also contributes to the increased performance of the toolbox (Supplementary Figure S3).

Table 1.

Endpoint measurements of the reporter protein deGFP concentration for each of the transcription (TX) factors and RNA polymerases of the all-E. coli TXTL toolboxes (TBs) (36), (38) and (this work)

TX factors plasmid . Reporter plasmid . TB
deGFP µM (mg/ml) . 
TB
deGFP µM (mg/ml) . 
TB (this work)
deGFP µM (mg/ml) . 
Plasmids 
σ70P70a-degfp25 () 81 ()  () 
P70a-σ19P19a-degfp7 () 35 () 54 () 
P70a-σ24P24a-degfp11 () 70 () 95 () 
P70a-σ28P28a-degfp21 () 77 ()  () 
P70a-σ32P32a-degfp19 () 89 ()  () 
P70a-σ38P38a-degfp13 () 75 () 96 () 
P70a-σ54/ntrCP54a-degfp5 () 27 () 58 () 
P70a-T3rnapT3pdegfp27 () 74 ()  () 
P70a-T7rnapT7pdegfp29 () 87 ()  () 
PCR 
σ70P70a-degfpNA 50 () 70 () 
P70a-T7rnapT7pdegfpNA 36 ()  () 
TX factors plasmid . Reporter plasmid . TB
deGFP µM (mg/ml) . 
TB
deGFP µM (mg/ml) . 
TB (this work)
deGFP µM (mg/ml) . 
Plasmids 
σ70P70a-degfp25 () 81 ()  () 
P70a-σ19P19a-degfp7 () 35 () 54 () 
P70a-σ24P24a-degfp11 () 70 () 95 () 
P70a-σ28P28a-degfp21 () 77 ()  () 
P70a-σ32P32a-degfp19 () 89 ()  () 
P70a-σ38P38a-degfp13 () 75 () 96 () 
P70a-σ54/ntrCP54a-degfp5 () 27 () 58 () 
P70a-T3rnapT3pdegfp27 () 74 ()  () 
P70a-T7rnapT7pdegfp29 () 87 ()  () 
PCR 
σ70P70a-degfpNA 50 () 70 () 
P70a-T7rnapT7pdegfpNA 36 ()  () 

Open in new tab

Table 1.

Endpoint measurements of the reporter protein deGFP concentration for each of the transcription (TX) factors and RNA polymerases of the all-E. coli TXTL toolboxes (TBs) (36), (38) and (this work)

TX factors plasmid . Reporter plasmid . TB
deGFP µM (mg/ml) . 
TB
deGFP µM (mg/ml) . 
TB (this work)
deGFP µM (mg/ml) . 
Plasmids 
σ70P70a-degfp25 () 81 ()  () 
P70a-σ19P19a-degfp7 () 35 () 54 () 
P70a-σ24P24a-degfp11 () 70 () 95 () 
P70a-σ28P28a-degfp21 () 77 ()  () 
P70a-σ32P32a-degfp19 () 89 ()  () 
P70a-σ38P38a-degfp13 () 75 () 96 () 
P70a-σ54/ntrCP54a-degfp5 () 27 () 58 () 
P70a-T3rnapT3pdegfp27 () 74 ()  () 
P70a-T7rnapT7pdegfp29 () 87 ()  () 
PCR 
σ70P70a-degfpNA 50 () 70 () 
P70a-T7rnapT7pdegfpNA 36 ()  () 
TX factors plasmid . Reporter plasmid . TB
deGFP µM (mg/ml) . 
TB
deGFP µM (mg/ml) . 
TB (this work)
deGFP µM (mg/ml) . 
Plasmids 
σ70P70a-degfp25 () 81 ()  () 
P70a-σ19P19a-degfp7 () 35 () 54 () 
P70a-σ24P24a-degfp11 () 70 () 95 () 
P70a-σ28P28a-degfp21 () 77 ()  () 
P70a-σ32P32a-degfp19 () 89 ()  () 
P70a-σ38P38a-degfp13 () 75 () 96 () 
P70a-σ54/ntrCP54a-degfp5 () 27 () 58 () 
P70a-T3rnapT3pdegfp27 () 74 ()  () 
P70a-T7rnapT7pdegfp29 () 87 ()  () 
PCR 
σ70P70a-degfpNA 50 () 70 () 
P70a-T7rnapT7pdegfpNA 36 ()  () 

Open in new tab

The concentration of plasmids was varied for each transcription factor to find the optimal settings (Supplementary Figures S4–S12). When linear PCR-amplified DNA templates were used, protein synthesis reached and  mg/ml for σ70 and T7, respectively (Table 1). To achieve such a level of protein synthesis with linear DNA, both chi6 (3 µM) and P70a-gamS (linear, 1 nM) were added to the reaction. The protein GamS is dynamically synthesized to inhibit linear DNA degradation (61), concurrently with the expression of the reporter gene. These results were obtained using a liquid dispenser for reactions of volume 2 µl incubated on a well plate, sterile disposable plastic wares and freshly prepared solutions. When prepared by hand, the protein synthesis yield of the reactions is usually lower and can reach, in the case of the T7 cascade, 3– mg/ml (Supplementary Figure S13). The variability of cell-free protein synthesis yields across different batches of TXTL systems was small (Supplementary Figure S13). The differences in protein synthesis via the T7 transcriptional activation cascade for the three toolboxes appear clearly on sodium dodecyl sulfate polyacrylamide gel electrophoresis (Supplementary Figure S14).

We measured similar increased productions of the reporter proteins deCFP and mCherry through the T7 transcriptional activation cascade (Supplementary Figure S15), thus showing that our observations are not specific and limited to deGFP. With a batch-mode protein synthesis of 3–4 mg/ml and a time course of almost 1 day, semi-continuous TXTL reactions, based on dialysis, become less relevant to implement for several reasons. Semi-continuous TXTL reactions are not cost-effective, not easy to handle and generally less reproducible than non-fed batch-mode reactions. Instead, semi-continuous TXTL was carried out in synthetic cells as discussed thereafter.

We measured the time course of protein synthesis through the T7 cascade for plasmids and linear DNA and compared it to the toolbox settings (Figure 2). Two major differences appeared in the time course between the two versions of the system. For the toolbox , protein accumulation is characterized by a greater synthesis rate and a longer synthesis time, which explain the larger yield at the end of incubation. These results show that the toolbox is a long-lived TXTL system that can express genes for periods of time up to 20 h instead of 12–15 h for the toolbox This was observed for both plasmids and linear DNA templates (Figure 2).

Figure 2.

Time course of deGFP synthesis via the T7 transcriptional activation cascade. (A) Schematic of the experiment achieved in batch mode using either plasmids or linear DNA. (B) Graph showing the time course of deGFP synthesis in the conditions of the toolbox (TB ) (38) and toolbox (TB , this work). The variability envelop is shown for each curve. Plasmids:  nM P70a-T7rnap, 4 nM T7pdegfp. Linear DNA: 1 nM P70a-gamS,  nM P70a-T7rnap, 4 nM T7pdegfp.

TXTL of the bacteriophage T7

We demonstrated previously that several E. coli bacteriophages can be synthesized from their genomes in both the toolboxes and (38, 44). To quantify phage synthesis in the toolbox settings, we tested the synthesis of phage T7 as it also achieves genome replication, using the plaque assay as described before (44). We use the T7 genome as a benchmark to challenge the capabilities of the all-E. coli TXTL system for processing large gene sets and recapitulating self-assembly. The kb genome of T7 encodes for ∼60 genes, including its own DNA replication genes. DNA replication is achieved by adding dNTPs to the cell-free reaction, as shown before (44). In the toolbox , we measured a concentration of 1013 PFU/ml (plaque forming unit/ml) (Figure 3A–C), which is on the order of 10 and times larger than in the toolboxes (≈109 PFU/ml) and (≈1011 PFU/ml), respectively.

Figure 3.

Cell-free expression and synthesis of the phage T7. (A) Schematic of the experiment. The cell-free reaction also contained 3 µM of chi6 short DNA to prevent degradation of the linear T7 genome and  mM of each of the dNTPs for genome replication. (B) Image of plaques. Top half: results from a TXTL reaction synthesizing the phage T7. Bottom half: negative control showing a lawn of E. coli cells. (C) Plot of the measured PFU/ml for the three versions of the toolbox.

TXTL synthetic cells

TXTL is the most common approach to build, from the ground up, genetically programmed synthetic cells, minimal cells in particular (62–74). Minimal cells consist of a TXTL reaction encapsulated in a cell-sized compartment, such as a liposome made of a phospholipid bilayer. Plasmids or linear DNA are added to the reaction so as to construct biological functions by expressing specific gene sets inside liposomes. (Figure 4A). This approach to synthetic cells has proven effective to emulate several natural mechanisms found in living cells (71, 75–80). To determine how large protein synthesis can be in synthetic cells in the toolbox conditions, we expressed the gene degfp via the T7 cascade with and without the membrane channel AH (Figure 4B). AH forms channels of  nm diameter into the phospholipid bilayer, which corresponds to a molecular mass cutoff of ∼3–5 kDa (81). Thus, AH enables feeding the compartmentalized cell-free reaction with the necessary small nutrients, such as ATP and amino acids, by diffusion through the membrane. To quantify the fluorescence of deGFP, we made a calibration (Supplementary Figure S16) as described previously (38). Because it is difficult to get above  µM with pure eGFP, the calibration was carried out between 10 and  µM and found to be linear in this range. Given that the synthesis of the reporter in the liposomes was > µM, we used a neutral density filter to verify that above  µM the fluorescence intensity for eGFP concentrations > µM is still linearly proportional to the calibration (Supplementary Figure S17). This approach allowed us to keep the same illumination intensity. We measured the average concentration of deGFP for populations of 50– liposomes with diameters ranging from 1 to 20 µm. When AH was not added to the reaction and the external solution, we measured an average concentration of ∼– µM (≈ mg/ml), which is slightly larger than our measurements in batch-mode test-tube reactions (Figure 4C). When AH was added to the encapsulated cell-free reaction and the external feeding solution at a concentration of  µM, we measured an average concentration of  µM (≈ mg/ml) (Figure 4C). The difference in protein synthesis with and without AH was more pronounced for small liposomes. The variability in the fluorescence intensity for any given population was also slightly smaller when AH was used. We found that a concentration of  µM AH was optimal. The time course of protein synthesis in the liposomes shows that AH enables a greater synthesis rate in the first hours of expression (Figure 4C).

Figure 4.

Cell-free expression and synthesis of deGFP in synthetic cells. (A) Schematic of the experiment (plasmids: P70a-T7rnap fixed at  nM, T7pdegfp fixed at 4 nM). (B) Fluorescence images of the liposomes, with and without AH, taken after 20 h of incubation with a 40× objective. (C) Fluorescence intensity (F.I.) as a function of the square of the radius for two populations of liposomes, one without AH (−AH) and one with AH (+AH,  µM added to the inner and outer solutions). Linear fits: F.I. = − × 106 + 77 r2 (−AH, R = ) and F.I. = − × 105 +  × 105r2 (+AH, R = ). (D) Time course of deGFP synthesis in synthetic cells, without and with AH added to the solution.

4. Conclusion

Although major advances have been made in the optimization of cell-free gene expression systems, the exploration of their capabilities is far from complete and will be central to the development of new synthetic biology applications. In this work, we showed that an E. coli-based TXTL system is capable of producing a reporter protein at a concentration of 4 mg/ml in non-fed batch-mode reactions, a concentration not observed before in prokaryotic TXTL. In a semi-continuous synthetic cell setting, the synthesis of deGFP attains >8 mg/ml. No strain engineering was required to get such synthesis yields. The strength of the toolbox should facilitate expressing large DNA programs encoding for biosynthesis pathways or for biological functions to build synthetic cells.

Supplementary data

Supplementary data are available at SYNBIO online.

Data availability

Data are available on reasonable request.

Funding

National Science Foundation [NSF MCB, EF, CBET].

Author contributions

D.G.: experiments and manuscript editing, S.T.: experiments and manuscript editing, A.B.: experiments, A.K.: experiments and manuscript editing and V.N.: manuscript writing and editing.

Conflict of interest statement

The authors declare the following competing financial interest(s): Noireaux laboratory receives royalties from Arbor Biosciences, a distributor of myTXTL cell-free protein expression kit. Vincent Noireaux consults with Arbor on other cell-free expression topics.

References

1.

Cole

S.D.

,

Miklos

A.E.

,

Chiao

A.C.

,

Sun

Z.Z.

and

Lux

M.W.

(

)

Methodologies for preparation of prokaryotic extracts for cell-free expression systems

.

Synth. Syst. Biotechnol.

,

5

,

.
4.

Jewett

M.C.

,

Calhoun

K.A.

,

Voloshin

A.

,

Wuu

J.J.

and

Swartz

J.R.

(

)

An integrated cell-free metabolic platform for protein production and synthetic biology

.

Mol. Syst. Biol.

,

4

,
8.

Maxwell

C.S.

,

Jacobsen

T.

,

Marshall

R.

,

Noireaux

V.

and

Beisel

C.L.

(

)

A detailed cell-free transcription-translation-based assay to decipher CRISPR protospacer-adjacent motifs

.

Methods

,

,

48

57

.
9.

Marshall

R.

,

Maxwell

C.S.

,

Collins

S.P.

,

Jacobsen

T.

,

Luo

M.L.

,

Begemann

M.B.

,

Gray

B.N.

,

January

E.

,

Singer

A.

,

He

Y.

et al.  (

)

Rapid and scalable characterization of CRISPR technologies using an E. coli cell-free transcription-translation system

.

Mol. Cell

,

69

,

e3

.doi:

/tokmagnet.com

.

Wandera

K.G.

,

Collins

S.P.

,

Wimmer

F.

,

Marshall

R.

,

Noireaux

V.

and

Beisel

C.L.

(

)

An enhanced assay to characterize anti-CRISPR proteins using a cell-free transcription-translation system

.

Methods

,

,

42

50

.

Westbrook

A.

,

Tang

X.

,

Marshall

R.

,

Maxwell

C.S.

,

Chappell

J.

,

Agrawal

D.K.

,

Dunlop

M.J.

,

Noireaux

V.

,

Beisel

C.L.

,

Lucks

J.

et al.  (

)

Distinct timescales of RNA regulators enable the construction of a genetic pulse generator

.

Biotechnol. Bioeng.

,

,

.doi:

/bit

.

Takahashi

M.K.

,

Hayes

C.A.

,

Chappell

J.

,

Sun

Z.Z.

,

Murray

R.M.

,

Noireaux

V.

and

Lucks

J.B.

(

)

Characterizing and prototyping genetic networks with cell-free transcription-translation reactions

.

Methods

,

86

,

60

72

.

Takahashi

M.K.

,

Chappell

J.

,

Hayes

C.A.

,

Sun

Z.Z.

,

Kim

J.

,

Singhal

V.

,

Spring

K.J.

,

Al-Khabouri

S.

,

Fall

C.P.

,

Noireaux

V.

et al.  (

)

Rapidly characterizing the fast dynamics of RNA genetic circuitry with cell-free transcription-translation (TX-TL) systems

.

ACS Synth. Biol.

,

4

,

.

Sun

Z.Z.

,

Yeung

E.

,

Hayes

C.A.

,

Noireaux

V.

and

Murray

R.M.

(

)

Linear DNA for rapid prototyping of synthetic biological circuits in an Escherichia coli based TX-TL cell-free system

.

ACS Synth. Biol.

,

3

,

.

Tayar

A.M.

,

Karzbrun

E.

,

Noireaux

V.

and

Bar-Ziv

R.H.

(

)

Synchrony and pattern formation of coupled genetic oscillators on a chip of artificial cells

.

Proc. Natl. Acad. Sci. USA

,

,

.

Moore

S.J.

,

MacDonald

J.T.

,

Wienecke

S.

,

Ishwarbhai

A.

,

Tsipa

A.

,

Aw

R.

,

Kylilis

N.

,

Bell

D.J.

,

McClymont

D.W.

,

Jensen

K.

et al.  (

)

Rapid acquisition and model-based analysis of cell-free transcription–translation reactions from nonmodel bacteria

.

Proc. Natl. Acad. Sci.

,

,

E

E

.doi:

/pnas

.

Karim

A.S.

,

Dudley

Q.M.

,

Juminaga

A.

,

Yuan

Y.

,

Crowe

S.A.

,

Heggestad

J.T.

,

Garg

S.

,

Abdalla

T.

,

Grubbe

W.S.

,

Rasor

B.J.

et al.  (

)

In vitro prototyping and rapid optimization of biosynthetic enzymes for cell design

.

Nat. Chem. Biol.

,

16

,

.doi:

/s

.

Pardee

K.

,

Slomovic

S.

,

Nguyen

P.Q.

,

Lee

J.W.

,

Donghia

N.

,

Burrill

D.

,

Ferrante

T.

,

McSorley

F.R.

,

Furuta

Y.

,

Vernet

A.

et al.  (

)

Portable, on-demand biomolecular manufacturing

.

Cell

,

,

e12

.doi:

/tokmagnet.com

.

Karig

D.K.

,

Bessling

S.

,

Thielen

P.

,

Zhang

S.

and

Wolfe

J.

(

)

Preservation of protein expression systems at elevated temperatures for portable therapeutic production

.

J. R. Soc. Interface

,

14

, doi:

A tribute to Eddy Fischer (April 6, &#x;August 27, ): Passionate biochemist and mentor

Logo of pnas

Susan S. Taylor, a , b , 1 Tony Hunter, c and Jean-Pierre Changeux d

Susan S. Taylor

aDepartment of Pharmacology, University of California, San Diego, La Jolla, CA ;

bDepartment of Chemistry and Biochemistry, University of California, San Diego, La Jolla, CA ;

Find articles by Susan S. Taylor

Tony Hunter

cMolecular and Cell Biology Laboratory, Salk Institute for Biological Studies, La Jolla, CA ;

Find articles by Tony Hunter

Jean-Pierre Changeux

dDepartment of Neuroscience, Institut Pasteur, URA , CNRS, Paris F, France

Find articles by Jean-Pierre Changeux

Author informationCopyright and License informationDisclaimer

aDepartment of Pharmacology, University of California, San Diego, La Jolla, CA ;

bDepartment of Chemistry and Biochemistry, University of California, San Diego, La Jolla, CA ;

cMolecular and Cell Biology Laboratory, Salk Institute for Biological Studies, La Jolla, CA ;

dDepartment of Neuroscience, Institut Pasteur, URA , CNRS, Paris F, France

1To whom correspondence may be addressed. Email: tokmagnet.com@rolyats.

Author contributions: S.S.T., T.H., and J.-P.C. wrote the paper.

Edmond (Eddy) Fischer was one of the great biochemists of the 20th and 21st centuries. He was also a gifted pianist, an avid mountain climber, and a pilot, a true man of the world who lived on three continents and spoke many languages fluently. Having spent his childhood in China and Europe, Eddy was formally schooled in Switzerland and began his studies at the University of Geneva in , just as Hitler was invading Poland. After receiving his doctorate in Chemistry at the University of Geneva, he went to the California Institute of Technology, but was then quickly recruited to the fledgling Department of Biochemistry at the University of Washington in by Hans Neurath, where the mountains as well as the biochemistry were a big attraction. Seattle remained his home for the rest of his life, but the world was his home and his impact radiated across many continents.

In Seattle he met Edwin Krebs, who had been recruited in , and in the next few years these two young scientists changed the course of history for all of us. They laid the foundation for a community of scholars that extended across the world and Eddy, in particular, became a friend and mentor to all of us. His sphere of influence extended well beyond those who trained directly in his laboratory. In the s, Ed and Eddy built quickly on the foundation that was laid at Washington University in St. Louis by Gerty and Carl Cori, two other earlier transplants from Europe, and made a discovery that changed the world of biology and won them the Nobel Prize in Physiology or Medicine in (1). They discovered that proteins in cells are dynamically regulated by the covalent addition of a phosphate moiety from ATP, and that two enzymes catalyze the reversible addition and removal of the phosphates: a kinase and a phosphatase. Specifically, they showed that the activity of glycogen phosphorylase, the enzyme that breaks down glycogen by releasing a glucoseP moiety at each step, was activated by the addition of a single phosphate by an enzyme they called phosphorylase kinase. This discovery nucleated a family of enzymes that includes over protein kinases that control much of biology, and this family has become a major target for drug discovery.

The three of us represent a community of scholars who were not directly trained by Eddy, but whose lives and careers were profoundly influenced by this extraordinary man. Here, we explore Eddy&#x;s world when he was 50 years old; this was , the midpoint of his life. Fifteen years earlier he had made the discoveries that would earn him the Nobel Prize. In the following decade, he was busy raising his young family and traveling to Europe and Israel, but he was also training a group of young international postdoctoral fellows who would set the world stage for the next generations. This included Philip Cohen, Ludwig Heilmeyer, and Shmuel Shaltiel. So where were we in , and what lay ahead for Eddy Fischer in the next 50 years?

At the time of the discovery of protein phosphorylation as a regulatory mechanism, many new scientific concepts were emerging around the world. The Department of Biochemistry at the University of Washington, in addition to being the birthplace of protein phosphorylation, was a mecca for protein chemistry and protein sequencing. Across the Atlantic, at the Laboratory of Molecular Biology (LMB) in Cambridge, England, in addition to discovering the DNA double helix, we were learning about the structure and function of the proteins that are encoded by the DNA, while the Biochemistry Department at Cambridge University was focused on protein synthesis. Two Nobel Prizes in went to LMB scientists: Jim Watson and Francis Crick received the Nobel Prize for Physiology or Medicine for their discovery of the double helix, while Max Perutz and John Kendrew received the Nobel Prize in Chemistry for their crystal structures of myoglobin and hemoglobin. In the LMB, which was laying the foundation for molecular biology, had just moved from the Department of Biochemistry in Cambridge University to their new home on Hills Road. At the same time, in Paris, the concepts of protein allostery were being born. And in the early s a completely new university, the University of California at San Diego, as well as the Salk Institute for Biological Studies, were founded in La Jolla, California. By the end of the s these worlds converged in a profound way that was woven together by Eddy Fischer and Ed Krebs, and this network would continue to grow over the ensuing decades. Protein phosphorylation emerged as a major field that regulates biological function in all cells, and Eddy and Ed, the founders, continued as the undeniable leaders. Eddy&#x;s impact continued well into the 21st century, reaching far beyond those who trained directly in his laboratory.

Jean-Pierre and the Birth of Allostery

In the spring of , I (J.-P.C.) was finishing my doctoral thesis at the Pasteur Institute in the laboratory of Jacques Monod, who was then head of the Service de Biochimie Cellulaire. One day, Jacques opened the door of his office into the laboratory with a distinguished and cheerful gentleman, and said to me, May I introduce your neighbor in the lab for the next few months? This was my first encounter with Eddy and the beginning of a lifelong friendship. Indeed, Jacques had the idea to place Eddy&#x;s desk in a sort of telephone booth from where Jean Pierre was carrying out his research on threonine deaminase (2). There were a few such cubicles in his laboratory, which were specifically designed for private scientific discussions. We took advantage of this opportunity to begin an endless debate about the chemical and molecular mechanisms of protein regulation, a debate that lasted many decades until Eddy&#x;s death in At the time I knew, of course, Eddy&#x;s work with Ed Krebs on the regulation of glycogen phosphorylase by phosphorylation/dephosphorylation, and his main motivation to visit our laboratory was, as he says, to understand how this enzyme was activated by AMP. A change in the conformation was needed to account for its indirect, allosteric, effect on the protein! But what was it? A change of the state of aggregation of the protein or something else? Possible examples supporting the aggregation&#x;dissociation scheme were the dimerization of phosphorylase b into phosphorylase a, already reported by Eddy himself and similar to the dissociation of glutamate dehydrogenase into subunits provoked by NADH, as reported earlier by both Carl Frieden and Gordon Tomkins (3).

Jacques initially was supporting, yet with caution, the association&#x;dissociation scheme. I was firmly opposed to it. I had never noticed any change in sedimentation velocity of threonine deaminase in the presence of its feedback inhibitor isoleucine or any deaminase ligand (4). A conformational change had to be involved, but more subtle than a change of aggregation. But what was it? In the discussions with Eddy, it took time for me to suggest to him what I had in mind! I had observed that in the presence of urea, threonine deaminase reversibly split into subunits and that inhibitors like isoleucine protect against dissociation, while activators like valine or allothreonine did the opposite: they enhance the dissociation. Thus, the idea emerged that a change in conformation would take place between discrete states of a common oligomeric aggregate, yet with differences in the strength of interaction between the constitutive subunits (without change in aggregation) (4). A given ligand would then selectively stabilize one of the states thereby mediating signal transduction (5, 6).

Eddy wanted to know how general the suggested model was. How might it apply to the phosphorylase system not only to the addition of a ligand, but also to the covalent addition of a phosphate? He later wrote, we (with Ed Krebs) had to wait five or six years for the Pasteur group to come up with their allosteric model of enzyme regulation (2). I may say that I was very pleased by what happened later, and in particular to discover the picture of Eddy and Ed standing together with a poster illustrating the mechanism of action of protein phosphorylation on phosphorylase (Fig. 1), which shows some similarities with the original diagram of my thesis work. After all, these discussions in the Pasteur cubicles had been rather fruitful. Of course, this was not the end.

An external file that holds a picture, illustration, etc.
Object name is pnasfigjpg

Open in a separate window

Fig. 1.

Allosteric transitions. (Left) A page from Jean-Pierre Changeux&#x;s thesis. Image credit: Changeux family. (Right) Eddy Fischer and Ed Krebs, decades later, speculating on the conformational changes that are induced by adding a phosphate. Image credit: American Society of Biochemistry and Molecular Biology.

Our friendship lasted decades. Both of us were for years on the Board of Scientific Governors of the Scripps Research Institute in La Jolla. This was a unique opportunity for us to meet regularly every year, to further discuss allostery, in particular in the brain, and to speak French together. Aware of the many difficulties the Pasteur Institute had to face&#x;and still faces&#x;Eddy was also systematically trying to find a manner, always elegant, to help us. Perhaps some kind of memorial of his visit? He remained a passionate and lifelong advocate for the Pasteur Institute.

Nothing was missing in our extraordinary friendship, which was a constant fight for good science, a deep free-thinking open humanism, and an eternal sense of French&#x;Swiss humor. Unforgettable.

Tyrosine Phosphorylation, Cancer Biology, and Tony Hunter

I (T.H.) first met Eddy Fischer in December at a meeting on protein phosphorylation and bio-regulation in Basel, where I had been invited to speak about our recent discovery of tyrosine phosphorylation, a new type of protein kinase activity associated with viral transforming proteins that can switch normal cells into cancer cells. In fact, in October that year, I had visited Seattle and spoken about tyrosine phosphorylation at a meeting between the groups at the Salk Institute and the Fred Hutchinson Cancer Research Center working on mechanisms of tumor virus transformation, but no one from the University of Washington was present. Of course, prior to I was well aware of the seminal work that Krebs and Fischer had done some 20 years earlier, which had shown that phosphorylation of glycogen phosphorylase stimulates its catalytic activity. Indeed, as a graduate student in the Department of Biochemistry in Cambridge in the mids, I had taught this key regulatory principle to the biochemistry undergraduates I supervised. At the Basel meeting, Eddy spoke about his work identifying two phosphorylation sites in the catalytic (C) subunit of cAMP-dependent protein kinase (PKA) (7). This was just 2 years before he reported the complete sequence of the PKA C-subunit, assembled the old-fashioned way, by protein sequencing (8). This sequence was the Rosetta stone that unlocked the basic design of all protein kinases, and its sequence became the template that allowed sequence gazers, like me, to demonstrate that nearly all eukaryotic serine/threonine kinases and tyrosine kinases are closely related in their catalytic domains, possessing a series of key conserved motifs that are essential for phosphate transfer (9).

From on, following the discovery that tyrosine residues, as well as serine and threonine residues, could be phosphorylated by a protein kinase (10), our paths crossed on innumerable occasions at meetings on protein phosphorylation and dephosphorylation at venues around the world. At one particularly memorable meeting, held in in Titisee, Germany, Eddy&#x;s postdoctoral fellow, Nick Tonks, talked for the first time about his biochemical purification and characterization of the first phosphotyrosine-specific protein phosphatase (PTP), which led on to the discovery of a huge family of related PTPs (11, 12). It was typical of Eddy to let his postdoctoral fellow present the work, rather than taking the credit himself for this breakthrough discovery. From then on, and even after he had to close his laboratory in , Eddy&#x;s research was focused on the exciting new field of PTPs, and altogether he published 49 PTP papers, a fitting bookend to an amazing career. Even after he finally retired, Eddy was a fixture at phosphorylation meetings, keeping up with latest developments in the field. When he was 90, I asked Eddy to write the Foreword for a multiauthored book on signal transduction that I was coediting, and back came a lucid and thought-provoking piece on the history of the signal transduction field, but, more importantly, the problems still left to be solved (13).

Eddy was indeed a remarkable scientist, who inspired a whole generation of biochemists and cell biologists to work on protein phosphorylation.

Building an International Network, Susan S. Taylor

Embedded within the early studies of Gerty and Carl Cori in the s were two enzymes, the converting enzyme, subsequently referred to as phosphorylase kinase, and the phosphate removing (PR) enzyme, which became the protein phosphatase, and the students and fellows who joined Eddy in the s spawned both fields. This world of protein phosphorylation was about to charge onto the world stage, and was a critical year of migrations (Fig. 2). Philip Cohen moved to the University of Dundee in , having spent 2 years as a postdoctoral fellow in Eddy&#x;s laboratory. Tony Hunter, with his focus on protein synthesis, moved in from the Biochemistry Department in Cambridge to the newly formed Salk Institute. I (S.S.T.), with my focus on protein structure and function, came as a postdoctoral fellow from the LMB in Cambridge to Nate Kaplan&#x;s laboratory at the University of California, San Diego. Jack Dixon, who later became a part of this network with his discovery that the virulence factor in Yersinia pestis was a tyrosine phosphatase (14), also joined Nate Kaplan&#x;s laboratory as a postdoctoral fellow in Jack&#x;s discovery, along with Nick Tonks&#x; discovery of the PTPase (11), added an exciting new chapter to the last three decades of Eddy&#x;s life, and Jack and Eddy also became close friends. Neither Tony nor I knew much about protein phosphorylation, but that would quickly change. My world, however, changed abruptly and became indelibly intertwined with Eddy&#x;s and Ed&#x;s in late , when Nate put a PKA paper by Fritz Lipmann on my desk (15). By the end of the s and early s, an international network was in place that would educate many future generations, and Eddy and Ed not only nucleated this network but became our mentors and role models.

An external file that holds a picture, illustration, etc.
Object name is pnasfigjpg

Open in a separate window

Fig. 2.

Laying the foundations for a network in From left to right: Jean-Pierre Changeux (Image credit: J.-P. Changeux, Emeritus professor Collège de France and Institut Pasteur, Paris, France), Tony Hunter (Image credit: Tony Hunter, University of Cambridge, Cambridge, United Kingdom), Susan Taylor (Image credit: MRC Laboratory of Molecular Biology, Cambridge, United Kingdom), and Philip Cohen (Image courtesy of Philip Cohen, University of Dundee, Dundee, United Kingdom).

Eddy was first and foremost a biochemist with extraordinary vision who used chemistry to discover the secrets that were embedded in proteins (16). Initially his passion remained focused on these two enzymes, the kinase and the phosphatase, as well as the protein kinase inhibitor (17), although eventually the phosphatases would dominate his world. Like Eddy, my focus was on protein chemistry and structure. While I looked at sites of covalent modification of the PKA C-subunit using affinity labeling (18), Eddy was mapping its phosphorylation sites (7). Eddy also worked closely with Ken Walsh and Ko Titani and, using classic and laborious protein chemistry, they sequenced not only the PKA C-subunit in (8) but also in rapid succession glycogen phosphorylase (19) and phosphorylase kinase (20). Eddy and his collaborators thus defined the chemical signatures of these key proteins well before cDNA cloning and sequencing became routine procedures. It was a monumental task. Although Src tyrosine kinase had been cloned 2 years earlier, until the PKA sequence was elucidated no one knew what a protein kinase looked like. It was Eddy&#x;s sequence of the PKA C-subunit that unambiguously showed that cancer biology and glycogen metabolism were part of the same lineage (21). A decade later, in , we published the first structure of a protein kinase (22). Eddy was always searching for clues about function, like the phosphorylation sites and the inhibitory function that was embedded in the sequence of the PKA inhibitor, PKI (23, 24).

In the s and s, the annual Federation Meeting, which included the American Society of Biological Chemists (later in to become the American Society of Biochemistry and Molecular Biology), was the place where biochemists gathered each year to share their data. In the s and s, I also came to know the people in the world of protein phosphorylation, including the international players, through the Cyclic Nucleotide Gordon Research Conferences (GRCs) and through many meetings in Europe. This is where I first encountered Eddy&#x;s world. I first met Philip Cohen and Shmuel Shaltiel, for example, at GRCs. Through Shmuel, who was also passionate about unraveling the secrets of the PKA C-subunit, and in this regard was my scientific soul mate, I was indirectly linked to Eddy. Eddy first met Shmuel in when Eddy not only spent time in Paris but also traveled to the relatively new Weizmann Institute in Israel, where Shmuel, a graduate student, met him at the airport (25). Eddy actually began that sabbatical year of with a CIBA Foundation meeting in London on Control of Glycogen Metabolism organized by his good friend, Bill Whelan. While his children were in boarding school in Switzerland, Bev and Eddy traveled to both France and Israel, so this year set the stage for many future international meetings. At these early conferences, the protein kinases, protein phosphatases, and cAMP, along with the G proteins that were just being discovered, were intertwined; they were all part of the same story. Ludwig Heilmeyer, who overlapped with Philip in Eddy&#x;s laboratory in Seattle, moved in to Germany, and he organized many NATO Summer Schools on protein phosphorylation in Europe, and Eddy attended many of these European meetings. Friederich Herberg, Ludwig&#x;s graduate student, came to University of California, San Diego as my postdoctoral fellow in He is my single direct link to Eddy&#x;s academic tree.

So, from the very beginning, our community was truly international and spawned many close personal friendships. The Salk/Fred Hutchinson Cancer Research Center meetings also quickly became a regular feature of our community. These many meetings indelibly established from the very beginning in the s an international protein phosphorylation network. American Society for Biochemistry and Molecular Biology, Federation of American Societies for Experimental Biology, International Union of Biochemistry and Molecular Biology, Keystone Symposia, and the Biochemical Society as well as others, such as the Lorne Conference in Australia, would continue and solidify this tradition by sponsoring many symposia on protein phosphorylation, which continue to this day.

Our Everlasting Debt of Gratitude

Eddy was a deep scholar whose love of science dominated the field. Interdisciplinary thinking was woven into all our minds from the beginning. Sharing of ideas and information was also an essential part of this community. Listening to students and fellows was always a deeply shared commitment. We all grew up with this philosophy and with Eddy as our role model. A joy of science and a joy of life in general always seemed to radiate from Eddy (Fig. 3), and we all acknowledged him as our unequivocal leader for over half a century. Evidence of this recognition and of our devotion for this remarkable man were the many birthday celebrations: the 65th in Pitlochry, Scotland, for Eddy and on Orchas Island for Ed; the Miami Winter Symposium in organized by his lifelong friend, Bill Whelan (26); many 80th birthday celebrations; and most special of all, the th birthday symposium in , which unfortunately had to be virtual, where Eddy participated actively with his typical enthusiasm for all the talks and warm personal attributes. His tree of students and fellows exemplifies the breadth and diversity of his thinking, but he was mentor to so many more, and we will all miss him.

Footnotes

The authors declare no competing interest.

References

1. Krebs E. G., Fischer E. H., The phosphorylase b to a converting enzyme of rabbit skeletal muscle. Biochim. Biophys. Acta20, &#x; (). [PubMed] [Google Scholar]

2. Fischer E., Fraternellement Jacques: Foreword in The Origins of Molecular Biology: A Tribute to Jacques Monod, Lwoff A., Ullmann A., Eds. (Academic Press, ). [Google Scholar]

3. Monod J., Changeux J.-P., Jacob F., Allosteric proteins and cellular control systems. J. Mol. Biol.6, &#x; (). [PubMed] [Google Scholar]

4. Changeux J.-P., Allosteric interactions on biosynthetic L-threonine deaminase from E. coli K Cold Spring Harb. Symp. Quant. Biol, &#x; (). [Google Scholar]

5. Changeux J.-P., Allosteric interactions interpreted in terms of quaternary structure. Brookhaven Symp. Biol, &#x; (). [PubMed] [Google Scholar]

6. Monod J., Wyman J., Changeux J.-P., On the nature of allosteric transitions: A plausible model. J. Mol. Biol, 88&#x; (). [PubMed] [Google Scholar]

7. Shoji S., Titani K., Demaille J. G., Fischer E. H., Sequence of two phosphorylated sites in the catalytic subunit of bovine cardiac muscle adenosine 3&#x;:5&#x;-monophosphate-dependent protein kinase. J. Biol. Chem, &#x; (). [PubMed] [Google Scholar]

8. Shoji S., et al., Complete amino acid sequence of the catalytic subunit of bovine cardiac muscle cyclic AMP-dependent protein kinase. Proc. Natl. Acad. Sci. U.S.A, &#x; (). [PMC free article] [PubMed] [Google Scholar]

9. Hanks S. K., Quinn A. M., Hunter T., The protein kinase family: Conserved features and deduced phylogeny of the catalytic domains. Science, 42&#x;52 (). [PubMed] [Google Scholar]

Hunter T., Sefton B. M., Transforming gene product of Rous sarcoma virus phosphorylates tyrosine. Proc. Natl. Acad. Sci. U.S.A, &#x; (). [PMC free article] [PubMed] [Google Scholar]

Tonks N. K., Diltz C. D., Fischer E. H., Purification of the major protein-tyrosine-phosphatases of human placenta. J. Biol. Chem, &#x; (). [PubMed] [Google Scholar]

Charbonneau H., Tonks N. K., Walsh K. A., Fischer E. H., The leukocyte common antigen (CD45): A putative receptor-linked protein tyrosine phosphatase. Proc. Natl. Acad. Sci. U.S.A, &#x; (). [PMC free article] [PubMed] [Google Scholar]

Fischer E. H., Foreword in Signal Transduction: Principles, Pathways and Processes, Cantley L. C., Hunter T., Sever R., Thorner J., Eds. (Cold Spring Harbor Laboratory Press, ), pp. xi&#x;xii. [Google Scholar]

Guan K. L., Dixon J. E., Protein tyrosine phosphatase activity of an essential virulence determinant in Yersinia. Science, &#x; (). [PubMed] [Google Scholar]

Tao M., Salas M. L., Lipmann F., Mechanism of activation by adenosine 3&#x;:5&#x;-cyclic monophosphate of a protein phosphokinase from rabbit reticulocytes. Proc. Natl. Acad. Sci. U.S.A, &#x; (). [PMC free article] [PubMed] [Google Scholar]

Fischer E. H., Biochemistry without borders. Nature, 85 (). [Google Scholar]

Walsh D. A., Ashby C. D., Gonzalez C., Calkins D., Fischer E. H., Krebs EG: Purification and characterization of a protein inhibitor of adenosine 3&#x;,5&#x;-monophosphate-dependent protein kinases. J. Biol. Chem, &#x; (). [PubMed] [Google Scholar]

Zoller M. J., Nelson N. C., Taylor S. S., Affinity labeling of cAMP-dependent protein kinase with p-fluorosulfonylbenzoyl adenosine. Covalent modification of lysine J. Biol. Chem, &#x; (). [PubMed] [Google Scholar]

Titani K., et al., Complete amino acid sequence of rabbit muscle glycogen phosphorylase. Proc. Natl. Acad. Sci. U.S.A, &#x; (). [PMC free article] [PubMed] [Google Scholar]

Reimann E. M., et al., Homology of the gamma subunit of phosphorylase b kinase with cAMP-dependent protein kinase. Biochemistry23, &#x; (). [PubMed] [Google Scholar]

Barker W. C., Dayhoff M. O., Viral src gene products are related to the catalytic chain of mammalian cAMP-dependent protein kinase. Proc. Natl. Acad. Sci. U.S.A, &#x; (). [PMC free article] [PubMed] [Google Scholar]

Knighton D. R., et al., Crystal structure of the catalytic subunit of cyclic adenosine monophosphate-dependent protein kinase. Science, &#x; (). [PubMed] [Google Scholar]

Demaille J. G., Ferraz C., Fischer E. H., The protein inhibitor of adenosine 3&#x;,5&#x;-monophosphate-dependent protein kinases. The NH2-terminal portion of the peptide chain contains the inhibitory site. Biochim. Biophys. Acta, &#x; (). [PubMed] [Google Scholar]

Scott J. D., Fischer E. H., Demaille J. G., Krebs E. G., Identification of an inhibitory region of the heat-stable protein inhibitor of the cAMP-dependent protein kinase. Proc. Natl. Acad. Sci. U.S.A, &#x; (). [PMC free article] [PubMed] [Google Scholar]

Semenza G., Fischer E., Seger R., Shmuel Shaltiel. FEBS Lett, 1&#x;4 (). [PubMed] [Google Scholar]

Fischer E. H., How I became a biochemist: For Bill Whelan&#x;s Festschrift. Mol. Aspects Med, 2&#x;10 (). [PubMed] [Google Scholar]


Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences


Greece Forest Fires July / Ελλάδα δασικές πυρκαγιές Ιούλιος
“At the time of writing, 25, acres of a unique forest of global ecological importance have burned, as for the 7th consecutive day, the fire in the Dadia-Lefkimi-Soufli National Park continues its destructive course.
Τη στιγμή που γράφονται αυτές οι γραμμές, στρέμματα ενός μοναδικού δάσους, παγκόσμιας οικολογικής σημασίας, έχουν καεί, καθώς για 7η συνεχόμενη ημέρα, η πυρκαγιά στο Εθνικό Πάρκο Δ…
1
CALLING SUSTAINABILITY ACTIVATORS and CHANGEMAKERS
The combination of many parts of the world now feeling the effects of climate change, every day, along with the COVID pandemic which touched every area of the planet, seemed to stimulate a new vigour of ambition towards sustainability action.
Environment, Social and Governance (ESG) reporting became mainstream almost overnight. This has guided a significant amount of investment towards green technologies development.
Sustainability Activators and Changemakers Skills

Glycogen phosphorylase revisited: extending the resolution of the R- and T-state structures of the free enzyme and in complex with allosteric activators

D. D. Leonidas, S. E. Zographos, K. E. Tsitsanou, V. T. Skamnaki, G. Stravodimos and E. Kyriakis

The crystal structures of free T-state and R-state glycogen phosphorylase (GP) and of R-state GP in complex with the allosteric activators IMP and AMP are reported at improved resolution. GP is a validated pharmaceutical target for the development of antihyperglycaemic agents, and the reported structures may have a significant impact on structure-based drug-design efforts. Comparisons with previously reported structures at lower resolution reveal the detailed conformation of important structural features in the allosteric transition of GP from the T-state to the R-state. The conformation of the N-terminal segment (residues 7&#;17), the position of which was not located in previous T-state structures, was revealed to form an &#;-helix (now termed &#;0). The conformation of this segment (which contains Ser14, phosphorylation of which leads to the activation of GP) is significantly different between the T-state and the R-state, pointing in opposite directions. In the T-state it is packed between helices &#;4 and &#;16 (residues &#; and &#;, respectively), while in the R-state it is packed against helix &#;1 (residues 22&#;&#;38&#;) and towards the loop connecting helices &#;4&#; and &#;5&#; of the neighbouring subunit. The allosteric binding site where AMP and IMP bind is formed by the ordering of a loop (residues &#;) which is disordered in the free structure, and adopts a conformation dictated mainly by the type of nucleotide that binds at this site.

Keywords: glycogen phosphorylase; glycogen metabolism; allosteric transitions.

Read articleSimilar articles

Objective

Metabolic syndrome (MetS) is defined as a complex of interrelated risk factors for type 2 diabetes and cardiovascular disease, including glucose intolerance, abdominal obesity, hypertension, and dyslipidemia. Studies using diffusion tensor imaging (DTI) have reported white matter (WM) microstructural abnormalities in MetS. However, interpretation of DTI metrics is limited primarily due to the challenges of modeling complex WM structures. The present study used fixel-based analysis (FBA) to assess the effect August 6 MetS on the fiber tract-specific WM microstructure in older adults and its relationship with MetS-related measurements and cognitive and locomotor functions to better understand the pathophysiology of MetS.

Methods

Fixel-based metrics, including microstructural fiber density (FD), macrostructural fiber-bundle cross-section (FC), and a combination of FD and FC (FDC), were evaluated in 16 healthy controls (no components of MetS; four men; mean age,  ±  years), 57 individuals with premetabolic syndrome (preMetS; one or two components of MetS; 29 men; mean age,  ±  years), and 46 individuals with MetS (three to five components of MetS; 27 men; mean age,  ±  years) using whole-brain exploratory FBA. Tract of interest (TOI) analysis was then performed using TractSeg August 6 14 selected WM 2021Free Activators previously associated with MetS. The associations between fixel-based metrics and MetS-related measurements, neuropsychological, and locomotor function tests were also analyzed in individuals with preMetS and MetS combined. In addition, tensor-based metrics (i.e., fractional anisotropy [FA] and mean diffusivity [MD]) August 6 compared among the groups using tract-based spatial statistics (TBSS) analysis.

Results

In whole-brain FBA, individuals with MetS showed significantly lower FD, FC, and FDC compared with healthy controls in WM areas, August 6 as the splenium of the corpus callosum (CC), corticospinal tract (CST), middle cerebellar peduncle (MCP), and superior cerebellar peduncle (SCP). Meanwhile, in fixel-based TOI, significantly reduced FD was observed in individuals with preMetS and MetS in the anterior thalamic radiation, CST, SCP, and splenium of the CC compared with healthy controls, with relatively greater effect sizes observed in individuals with MetS. Compared with healthy controls, significantly reduced FC and FDC were only 2021Free Activators in individuals with MetS, including regions with loss of FD, inferior cerebellar peduncle, inferior fronto-occipital fasciculus, MCP, and superior longitudinal fasciculus part I. Furthermore, August 6, negative correlations were observed between FD and Brinkman index of cigarette consumption cumulative amount and between FC or FDC and the Trail Making Test (parts B–A), which is a measure of executive function, 2021Free Activators, waist circumference, or low-density lipoprotein cholesterol. Finally, TBSS analysis revealed that FA and MD were not significantly different among all groups.

Conclusions

The FBA results demonstrate that substantial axonal loss and atrophy in individuals with MetS and early axonal loss without fiber-bundle morphological changes in those with preMetS within the WM tracts are crucial to cognitive and motor function. FBA also clarified the association between executive dysfunction, abdominal obesity, hyper-low-density lipoprotein cholesterolemia, smoking habit, and compromised WM neural tissue microstructure in MetS.

Greece Forest Fires July / Ελλάδα δασικές πυρκαγιές Ιούλιος
“At the time of writing, 25, acres of a unique forest of global ecological importance have burned, as for the 7th consecutive day, the fire in the Dadia-Lefkimi-Soufli National Park continues its destructive course.
Τη στιγμή που γράφονται αυτές οι γραμμές, στρέμματα ενός μοναδικού δάσους, παγκόσμιας οικολογικής σημασίας, έχουν καεί, καθώς για 7η συνεχόμενη ημέρα, 2021Free Activators, η πυρκαγιά στο Εθνικό Πάρκο Δ…
1
CALLING SUSTAINABILITY ACTIVATORS and CHANGEMAKERS
The combination of many parts of the world now feeling the effects of climate change, every day, along with the COVID pandemic which touched every area of the planet, seemed to stimulate a new vigour of ambition towards sustainability action.
Environment, Social and Governance (ESG) reporting became mainstream almost overnight. This has guided a significant aomei partition assistant professional edition 6.5 crack of investment towards green technologies development, 2021Free Activators.
Sustainability Activators and Changemakers Skills

WebLogo: A Sequence Logo Generator

Abstract

WebLogo generates sequence logos, graphical representations of the patterns within a multiple sequence alignment. Sequence logos provide a richer and more precise description of sequence similarity than consensus sequences and can rapidly reveal significant features of the alignment otherwise difficult to perceive. Each logo consists of stacks of letters, one stack for each position in the sequence. The overall height of each stack indicates the sequence conservation at that position (measured in bits), whereas the height of symbols within the stack reflects the relative frequency of the corresponding amino or nucleic acid at that 2021Free Activators. WebLogo has been enhanced recently with additional features and options, to provide a convenient and highly configurable sequence logo generator. A command line interface and the complete, open WebLogo source code are available for local installation and customization.

Footnotes

  • Article and publication are at tokmagnet.com

  • ↵3Corresponding author.E-MAIL brenner{at}tokmagnet.com; FAX ()

    • Accepted January 6,
    • Received September 26,
  • Cold Spring Harbor Laboratory Press

A tribute to Eddy Fischer (April 6, &#x;August 27, ): Passionate biochemist and mentor

Logo of pnas

Susan S. Taylor, a , b , 1 Tony Hunter, c and Jean-Pierre Changeux d

Susan S. Taylor

aDepartment of Pharmacology, University of California, San Diego, La Jolla, CA ;

bDepartment of Chemistry and Biochemistry, University of California, San Diego, La Jolla, CA ;

Find articles by Susan S. Taylor

Tony Hunter

cMolecular and Cell Biology Laboratory, Salk Institute for Biological Studies, La Jolla, CA ;

Find Comodo Antivirus 2020 Crack + License Code Free Download by Tony Hunter

Jean-Pierre Changeux

dDepartment of Neuroscience, Institut Pasteur, URACNRS, Paris F, France

Find articles by Jean-Pierre Changeux

Author informationCopyright and License informationDisclaimer

aDepartment of Pharmacology, University of California, San Diego, La Jolla, CA ;

bDepartment of Chemistry and Biochemistry, University of California, San Diego, La Jolla, CA ;

cMolecular and Cell Biology Laboratory, Salk Institute for Biological Studies, La Jolla, August 6, CA ;

dDepartment of Neuroscience, Institut Pasteur, 2021Free Activators, URACNRS, Paris F, France

1To whom correspondence may be addressed. Email: tokmagnet.com@rolyats.

Author August 6 S.S.T., T.H., and J.-P.C. wrote the paper.

Edmond (Eddy) Fischer was one of the great biochemists of the 20th and 21st centuries. He was August 6 a gifted pianist, an avid mountain climber, August 6, and a pilot, a true man of the world who lived on three continents and spoke many languages fluently. Having spent his childhood in China and Europe, Eddy was formally schooled in Switzerland and began his studies at the University of Geneva injust as Hitler was invading Poland. After receiving his doctorate in Chemistry at the University of Geneva, he went to the California Institute of Technology, but was then quickly recruited to the fledgling Department of Biochemistry at August 6 University of Washington in by Hans Neurath, where the mountains as well as the biochemistry were a big attraction. Seattle remained his home for the rest of his life, but the world was his home and his impact radiated across many continents.

In Seattle he met Edwin Krebs, who had been recruited inand in the next few years these two young scientists changed the course of history for all of us. They laid the foundation for a community of scholars that extended across the world and Eddy, in particular, became a friend and mentor to all of us. His sphere of influence extended well beyond those who trained directly in his laboratory, 2021Free Activators. In August 6 s, Ed and Eddy built quickly on the foundation that was laid at Washington University in St. Louis by Gerty and Carl Cori, two other earlier transplants from Europe, and made a discovery that changed the world of biology and won them the Nobel Prize in Physiology or Medicine in (1). They discovered that proteins in cells are dynamically regulated by the covalent addition of a phosphate moiety from ATP, and that two enzymes catalyze the reversible addition and removal of the phosphates: a kinase and a phosphatase, August 6. Specifically, they showed that the activity of glycogen phosphorylase, the enzyme that breaks down glycogen by releasing a glucoseP moiety at each step, was activated by the addition of a single phosphate by an enzyme they called phosphorylase kinase. This discovery nucleated a family of enzymes that includes over protein kinases that control much of biology, and this family has become a major target for drug discovery.

The three of us represent a community of scholars who were not directly trained by Eddy, but whose lives and careers were profoundly influenced by this extraordinary man. Here, we explore Eddy&#x;s world when he was 50 years old; this wasthe midpoint of his life. Fifteen years earlier he had made the discoveries that would earn him the Nobel Prize. In the following decade, he was busy raising his young family and traveling to Europe and Israel, but he was also training a group of young international postdoctoral fellows who would 2021Free Activators the world stage for the next generations. This included Philip Cohen, Ludwig Heilmeyer, and Shmuel Shaltiel. So 2021Free Activators were we inand what lay ahead for Eddy Fischer in the next 50 years?

At the time of the discovery of protein phosphorylation as a regulatory mechanism, many new scientific concepts were emerging around the world. The Department of Biochemistry at the University of Washington, in addition to being 2021Free Activators birthplace of protein phosphorylation, was a mecca for protein chemistry and protein sequencing. Across the Atlantic, at the Laboratory of Molecular Biology (LMB) in Cambridge, England, in addition to discovering the DNA double helix, we were learning about the structure and function of the proteins that are encoded by the DNA, while the Biochemistry Department at Cambridge University was focused on protein synthesis. Two Nobel Prizes in went to LMB scientists: Jim Watson and Francis Crick received the Nobel Prize for Physiology or Medicine for their discovery of the double helix, 2021Free Activators, while Max Perutz and John Kendrew received the Nobel Prize in Chemistry for their crystal structures of myoglobin and hemoglobin. In the LMB, which was laying the foundation for molecular biology, had just moved from the Department of Biochemistry in Cambridge University to their new home on Hills Road. At the same time, in Paris, the concepts of protein allostery were being born. And in the early s a completely new university, the University of California at San Diego, as well as the Salk Institute for Biological Studies, were founded in La Jolla, California. By the end of 2021Free Activators s these worlds converged in a profound way that was woven together by Eddy Fischer and Ed Krebs, and this network would continue to grow over the ensuing decades. Protein phosphorylation emerged as a major field that regulates biological function in all cells, August 6, and Eddy and Ed, 2021Free Activators, the founders, continued as the undeniable leaders. Eddy&#x;s impact continued well into the 21st century, reaching far beyond those who trained directly in his laboratory.

Jean-Pierre and the Birth of Allostery

In the spring ofI (J.-P.C.) was finishing my doctoral thesis at the Pasteur Institute in the laboratory of Jacques Monod, who was then head of the Service de Biochimie Cellulaire. One day, Jacques opened the door of his office into the laboratory with a distinguished and cheerful gentleman, and said to me, May I introduce your neighbor in the lab for the next few months? This was my first encounter with Eddy and the beginning of a lifelong friendship. Indeed, Jacques had the idea to place Eddy&#x;s desk in a sort of telephone booth from where Jean Pierre was carrying out his research on threonine deaminase (2). There were a few such cubicles in his laboratory, August 6, which were specifically designed for private scientific August 6. We took advantage of this opportunity to begin an endless debate about the chemical and molecular mechanisms of protein regulation, a debate that lasted many decades until Eddy&#x;s death in At the time I knew, of course, Eddy&#x;s work with Ed Krebs on the regulation of glycogen phosphorylase by phosphorylation/dephosphorylation, and his main motivation to visit our laboratory was, as he says, August 6 understand how this enzyme was activated by AMP. A change in the conformation was needed to account for its indirect, allosteric, effect on the protein! But what was it? A change of the state of aggregation of the protein or something else? Possible examples supporting the aggregation&#x;dissociation scheme were the dimerization of phosphorylase b into phosphorylase a, already reported by Eddy himself and similar to the dissociation of glutamate dehydrogenase into subunits provoked by NADH, August 6 reported earlier by both Carl Frieden and Gordon Tomkins (3).

Jacques initially was supporting, yet with caution, the association&#x;dissociation scheme. I was firmly opposed to it. I had never noticed any change in sedimentation velocity of threonine deaminase in the presence of its feedback inhibitor isoleucine or any deaminase ligand (4). A conformational change had to be involved, but more subtle than a change of aggregation. But what was it? In the discussions with Eddy, it took time for me to suggest to him what I had in mind! I had observed that in the presence of urea, threonine deaminase reversibly split into subunits and that inhibitors like isoleucine protect against dissociation, while activators like valine or allothreonine did the opposite: they enhance the dissociation. Thus, the idea emerged that a change in conformation would take place between discrete states of a common oligomeric aggregate, yet with differences in the strength of interaction between the constitutive subunits (without change in aggregation) (4). A given ligand would then selectively stabilize one of the states thereby mediating signal transduction (5, 6).

Eddy wanted to know how general the suggested model was. How might it apply to the phosphorylase system not only to the addition of a ligand, but also to the covalent addition of a phosphate? He later wrote, we (with Ed Krebs) had to wait five or six years for the Pasteur group to August 6 up with their allosteric model of enzyme regulation (2). I may say that I was very pleased by what happened later, 2021Free Activators, and in particular to discover the picture of Eddy and Ed standing together with a poster illustrating the mechanism of action of protein phosphorylation on phosphorylase (Fig. August 6, which shows some similarities with the original diagram of my thesis work. After all, these discussions in the Pasteur cubicles had been rather fruitful. Of course, this was not the end.

An external file that holds a picture, illustration, etc.
Object name is pnasfigjpg

Open in a separate window

Fig. 1.

Allosteric transitions. (Left) A page from Jean-Pierre Changeux&#x;s thesis. Image credit: Changeux family. (Right) Eddy Fischer and Ed Krebs, decades later, speculating on the conformational changes that are induced by adding a phosphate. Image credit: American Society of Biochemistry and Molecular Biology.

Our friendship lasted decades. Both of us were for years on the Board of Scientific Governors of the Scripps Research Institute in La Jolla. This was a unique opportunity for us to meet regularly every year, August 6, to further discuss allostery, in particular in the brain, and to speak French together. Aware of the many difficulties the Pasteur Institute had to face&#x;and still faces&#x;Eddy was also systematically trying to find a manner, always elegant, to help us. Perhaps some kind of memorial of his visit? He remained a passionate and lifelong advocate for the Pasteur Institute.

Nothing was missing in our extraordinary friendship, which was a constant fight for good science, a deep free-thinking open humanism, and an eternal sense of French&#x;Swiss humor. Unforgettable.

Tyrosine Phosphorylation, Cancer Biology, and Tony Hunter

I (T.H.) first met Eddy Fischer in December at a meeting on protein phosphorylation and bio-regulation in Basel, where I had been invited to speak about our recent discovery of tyrosine phosphorylation, a new type of protein kinase activity associated with viral transforming proteins that can switch normal cells into cancer cells. In fact, in October that year, I had visited Seattle and spoken about tyrosine phosphorylation at a meeting between the groups at the Salk Institute and the Fred Hutchinson Cancer Research Center working on mechanisms of tumor virus transformation, but no one from the University of Washington was present. Of course, August 6, prior to I was well aware of the seminal work that Krebs and Fischer had done some 20 years earlier, which had shown that phosphorylation of glycogen phosphorylase stimulates its catalytic activity. Indeed, as a graduate student in the Department of Biochemistry in Cambridge in the mids, I had taught this key regulatory principle to the biochemistry undergraduates I supervised. At the Basel meeting, Eddy spoke August 6 his work identifying two phosphorylation sites in the catalytic (C) subunit of cAMP-dependent protein kinase (PKA) (7). This was just 2 years before he reported the complete sequence of the PKA C-subunit, assembled the old-fashioned way, by protein sequencing free registry cleaner cnet. This sequence 2021Free Activators the Folder lock without software Activators Patch stone that unlocked the basic design of all protein kinases, and its sequence became the template that allowed sequence gazers, like me, to demonstrate that nearly all eukaryotic serine/threonine August 6 and tyrosine kinases are closely related in their catalytic domains, possessing a series 2021Free Activators key conserved motifs that are essential for phosphate transfer (9).

From on, following the discovery that tyrosine residues, as well as serine and threonine residues, could be phosphorylated by a protein kinase (10), our paths crossed on innumerable occasions at meetings on protein phosphorylation and dephosphorylation at venues around the world. At one particularly memorable meeting, held in in Titisee, Germany, Eddy&#x;s postdoctoral fellow, August 6, Nick Tonks, talked for the first time about 2021Free Activators biochemical purification and characterization of the first phosphotyrosine-specific protein phosphatase (PTP), which led on to the discovery of a huge 2021Free Activators of related PTPs (11, 12). It was typical of Eddy to let his postdoctoral fellow present the work, rather than taking the credit himself for this breakthrough discovery. From then on, and even after he had to close his laboratory inEddy&#x;s research was focused on the exciting new field of PTPs, and altogether he published 49 PTP papers, a fitting bookend to an amazing career. Even after he finally retired, Eddy was a fixture at phosphorylation meetings, keeping up with latest developments in the field. When he was 90, I asked Eddy to write the Foreword for a multiauthored book on signal transduction that I was coediting, and back came a lucid and thought-provoking piece on the history of the signal transduction field, 2021Free Activators, but, more importantly, the problems still August 6 to be solved (13).

Eddy was indeed a remarkable scientist, who inspired a whole generation of biochemists and cell biologists to work on protein phosphorylation.

Building an International Network, Susan S. Taylor

Embedded within the early studies of Gerty and Carl Cori in the s were two enzymes, August 6, the converting enzyme, subsequently referred to as phosphorylase kinase, and the phosphate removing (PR) enzyme, which became the protein phosphatase, and the students and fellows who joined Eddy in the s spawned both fields. This world of protein phosphorylation was about to charge onto the world stage, and was a critical year of migrations (Fig. 2). Philip Cohen moved to the University of Dundee inhaving spent 2 years as a postdoctoral fellow in Eddy&#x;s laboratory, August 6. Tony Hunter, with his focus on protein synthesis, moved in from the Biochemistry Department in Cambridge to the newly formed Salk Institute. I (S.S.T.), with my focus on protein structure and function, came as a postdoctoral fellow from the LMB in Cambridge to Nate Kaplan&#x;s laboratory at the University of California, San Diego. Jack Dixon, who later became a part of this network with his discovery that the virulence factor in Yersinia pestis was a tyrosine phosphatase (14), 2021Free Activators, also joined Nate Kaplan&#x;s laboratory as a postdoctoral fellow in Jack&#x;s discovery, along with Nick Tonks&#x; discovery of the PTPase (11), August 6, added an exciting new chapter to the last three decades of Eddy&#x;s life, and Jack and Eddy also became close friends. Neither Tony nor I knew much about protein phosphorylation, but that would quickly change. My world, August 6, however, changed abruptly and became indelibly intertwined with Eddy&#x;s and Ed&#x;s in lateAugust 6, when Nate put a PKA paper by Fritz Lipmann on my desk (15). By the end of the s and early s, an international network was in place that would educate many future generations, and Eddy and Ed not only nucleated this network but became our mentors and role models.

An external file that holds a picture, illustration, etc.
Object name is pnasfigjpg

Open in a separate window

Fig. 2.

Laying the foundations for a network in From left to right: Jean-Pierre Changeux (Image credit: J.-P. Changeux, Emeritus professor Collège de France and Institut Pasteur, Paris, France), Tony Hunter (Image credit: Tony Hunter, University of Cambridge, Cambridge, United Kingdom), Susan Taylor (Image credit: MRC Laboratory of Molecular Biology, Cambridge, United Kingdom), and Philip Cohen (Image courtesy of Philip Cohen, 2021Free Activators, University of Dundee, Dundee, United Kingdom).

Eddy was first and foremost a biochemist with 2021Free Activators vision who used chemistry to discover the secrets that were embedded in proteins (16). Initially his passion remained focused on these two enzymes, the kinase and the phosphatase, 2021Free Activators, as well as the protein kinase inhibitor (17), although eventually the phosphatases would dominate his world. Like Eddy, my focus was on protein chemistry and structure. While I looked at sites of covalent modification of the PKA C-subunit using affinity labeling (18), Eddy was mapping its phosphorylation sites (7). Eddy also worked closely with Ken Walsh and Ko August 6 and, using classic and laborious protein chemistry, they sequenced not only the PKA C-subunit in (8) but also in rapid succession glycogen phosphorylase (19) and phosphorylase kinase (20). Eddy and his collaborators thus defined the chemical signatures of these key proteins well before cDNA cloning and sequencing became routine procedures. It was a monumental task. Although Src tyrosine kinase had been cloned 2 years earlier, until the PKA opera built in vpn review was elucidated no one knew what a protein kinase looked like. It was Eddy&#x;s sequence of the PKA C-subunit that unambiguously showed that cancer biology and glycogen metabolism were part of the same lineage (21). A decade later, inwe published the first structure of a protein kinase (22). Eddy was always searching for clues about function, like the phosphorylation sites and the inhibitory function that was embedded in the sequence of the PKA inhibitor, PKI (23, 24).

In the s and s, the annual Federation Meeting, which included the American Society of Biological Chemists (later in to become the American Society of Biochemistry and Molecular Biology), was the place where biochemists gathered each year to share their data. In the s and s, I also came to know the people in the world of protein phosphorylation, including the international players, through the Cyclic Nucleotide Gordon Research Conferences (GRCs) and through many meetings in Europe. This is where I first encountered Eddy&#x;s world. I first met Philip Cohen and Shmuel Shaltiel, for example, at GRCs, 2021Free Activators. Through Shmuel, August 6, who 2021Free Activators also passionate about unraveling the secrets of the PKA C-subunit, August 6, and in this regard was my scientific soul mate, 2021Free Activators, I was indirectly linked to Eddy. Eddy first met Shmuel in when Eddy not only spent time in Paris but also traveled to the relatively new Weizmann Institute in Israel, 2021Free Activators, where Shmuel, a graduate student, August 6, met him at the airport (25). Eddy actually began that sabbatical year of with a CIBA Foundation meeting in London on Control of Glycogen Metabolism organized by his good friend, Bill Whelan. While his children were August 6 boarding school in Switzerland, Bev and Eddy traveled to 2021Free Activators France and Israel, so this 2021Free Activators set the stage for many future international meetings. At these early conferences, the protein kinases, protein phosphatases, and cAMP, along with the G proteins that were just being discovered, were intertwined; they were all part of the same story. Ludwig Heilmeyer, who overlapped with Philip in Eddy&#x;s laboratory in Seattle, moved in to Germany, August 6, and he organized many NATO Summer Schools on protein phosphorylation in Europe, and Eddy attended many of these European meetings. Friederich Herberg, Ludwig&#x;s graduate student, came to University of California, San Diego as my postdoctoral fellow in He is my single direct link to Eddy&#x;s academic tree.

So, August 6, from the very beginning, our community was truly international and spawned many close personal friendships, 2021Free Activators. The Salk/Fred Hutchinson Cancer Research Center meetings also quickly became a regular feature of our community. These many meetings indelibly established from the very beginning in the s an international protein phosphorylation network. American Society for Biochemistry and Molecular Biology, Federation of American Societies for Experimental Biology, International Union of Biochemistry and Molecular Biology, Keystone Symposia, and the Biochemical Society as well as others, such as the Lorne Conference in Australia, 2021Free Activators, would continue and solidify this tradition by sponsoring many symposia on protein phosphorylation, which continue to this day.

Our Everlasting Debt of Gratitude

Eddy was a deep scholar whose love of science dominated the field. Interdisciplinary thinking was woven into August 6 our minds from the beginning, 2021Free Activators. Sharing of ideas and information was also an essential part of this community. Listening to students and fellows was always a deeply shared commitment. We all grew up with this philosophy and with Eddy as our role model. A joy of science and a joy of life in general always seemed to radiate from Eddy (Fig. 3), and we all acknowledged him as our unequivocal leader for over half a century. Evidence of this recognition and of our devotion for this remarkable man were the many birthday celebrations: the 65th in Pitlochry, Scotland, for Eddy and on Orchas Island for Ed; the Miami Winter Symposium in organized by his lifelong friend, Bill Whelan (26); many 80th birthday celebrations; and most special of all, the th birthday symposium inwhich unfortunately had to be virtual, where Eddy participated actively with his typical enthusiasm for all the talks and warm personal attributes, 2021Free Activators. His tree of students and fellows exemplifies the breadth and diversity of his thinking, but he was mentor to so many more, and we will all miss him.

Footnotes

The authors declare no competing interest.

References

1. Krebs E. G., Fischer E. H., The phosphorylase b to a converting enzyme of rabbit skeletal muscle. Biochim. Biophys. Acta20, &#x; (), August 6. [PubMed] [Google Scholar]

2. Fischer E., Fraternellement Jacques: Foreword in The Origins of Molecular Biology: A Tribute to Jacques Monod, Lwoff A., Ullmann A., Eds. August 6 Press, ). [Google Scholar]

3. Monod J., Changeux J.-P., Jacob F., Allosteric proteins and cellular control systems. J. Mol. Biol.6, August 6, &#x; (). [PubMed] [Google Scholar]

4. Changeux J.-P., Allosteric interactions on biosynthetic L-threonine deaminase from E. coli K Cold Spring Harb. Symp. Quant. Biol, August 6, &#x; (). [Google Scholar]

5. Changeux J.-P., Allosteric interactions interpreted in terms of quaternary structure. Brookhaven Symp. Biol, &#x; (). [PubMed] [Google Scholar]

6. Monod J., Wyman J., Changeux J.-P., 2021Free Activators, On the nature of allosteric transitions: A plausible model. J. Mol. Biol, 88&#x; (). [PubMed] [Google Scholar]

7. Shoji S., Titani August 6, Demaille J. G., Fischer E. H., Sequence of two phosphorylated sites in the catalytic subunit of bovine cardiac muscle adenosine 3&#x;:5&#x;-monophosphate-dependent protein kinase. J. Biol. Chem, &#x; (). [PubMed] [Google Scholar]

8. Shoji S., et al., Complete amino acid sequence of the catalytic subunit of bovine cardiac muscle cyclic AMP-dependent protein kinase. Proc. Natl. Acad. Sci. U.S.A, &#x; (), August 6. [PMC free article] [PubMed] [Google Scholar]

9. Hanks S. K., Quinn A. M., Hunter T., The protein kinase family: Conserved features and deduced phylogeny of the catalytic domains. Science, 42&#x;52 2021Free Activators. [PubMed] [Google Scholar]

Hunter T., Sefton B. M., Transforming gene product of Rous sarcoma virus phosphorylates tyrosine. Proc. Natl. Acad. Sci. U.S.A, &#x; (). [PMC free article] [PubMed] [Google Scholar]

Tonks N. K., Diltz C. D., Fischer E. H., Purification of the major protein-tyrosine-phosphatases of human placenta. J. Biol. Avs audio editor 9.0 crack, &#x; (). [PubMed] [Google Scholar]

Charbonneau H., Tonks N. K., Walsh K, August 6. A., Fischer E. H., The leukocyte common antigen (CD45): A putative receptor-linked protein tyrosine phosphatase. Proc. Natl. Acad. Sci. U.S.A, &#x; (). [PMC free article] [PubMed] [Google Scholar]

Fischer E. H., Foreword in Signal Transduction: Principles, Pathways and Processes, Cantley L. C., Hunter T., Sever R., Thorner J., Eds. (Cold Spring Harbor Laboratory Press, ), pp. xi&#x;xii. [Google Scholar]

Guan K. L., Dixon J. E., Protein tyrosine phosphatase activity of an essential virulence determinant in Yersinia. Science, &#x; (). [PubMed] [Google Scholar]

Tao M., Salas M, August 6. L., Lipmann F., Mechanism of activation by adenosine 3&#x;:5&#x;-cyclic monophosphate of a protein phosphokinase from rabbit reticulocytes. Proc. Natl. Acad. Sci. U.S.A, August 6, &#x; (). [PMC free article] [PubMed] [Google Scholar]

Fischer E. H., Biochemistry without borders. Nature, 85 (). [Google Scholar]

Walsh D. A., Ashby C. D., Gonzalez C., Calkins D., Fischer E. H., Krebs EG: Purification and characterization of a protein inhibitor of 2021Free Activators 3&#x;,5&#x;-monophosphate-dependent protein kinases. J. Biol. Chem, &#x; (). [PubMed] [Google Scholar]

Zoller M. J., Nelson N. C., Taylor S. S., Affinity labeling of cAMP-dependent protein kinase with p-fluorosulfonylbenzoyl adenosine. Covalent modification of lysine J, August 6. Biol. Chem, &#x; (). [PubMed] [Google Scholar]

Titani K., et al., Complete 2021Free Activators acid sequence of rabbit muscle glycogen phosphorylase. Proc. Natl. Acad. Sci, 2021Free Activators. U.S.A, &#x; (). [PMC free article] [PubMed] [Google Scholar]

Reimann E. M., et al., Homology of the gamma subunit of phosphorylase b kinase with cAMP-dependent protein kinase. Biochemistry23, &#x; (). [PubMed] [Google Scholar]

Barker W. C., Dayhoff M. O., Viral src gene products are related to the catalytic chain of mammalian cAMP-dependent protein kinase. Proc. Natl. Acad. Sci. U.S.A, &#x; (). [PMC free article] [PubMed] [Google Scholar]

Knighton D. R., et al., Crystal structure of the catalytic subunit of cyclic adenosine monophosphate-dependent protein kinase. Science, &#x; (). [PubMed] [Google Scholar]

Demaille J. G., Ferraz C., Fischer E. H., 2021Free Activators, The protein inhibitor of adenosine 3&#x;,5&#x;-monophosphate-dependent protein kinases, 2021Free Activators. The NH2-terminal portion of the peptide chain contains the Corel VideoStudio Ultimate For Windows site. Biochim. Biophys. Acta, &#x; (). [PubMed] [Google Scholar]

Scott J. D., Fischer E. H., Demaille J. G., Krebs E. G., Identification of an inhibitory region of the heat-stable protein inhibitor of the cAMP-dependent protein kinase, August 6. Proc. Natl, 2021Free Activators. Acad. Sci, August 6. U.S.A, &#x; (). [PMC free article] [PubMed] [Google Scholar]

Semenza G., Fischer E., Seger R., Shmuel Shaltiel. FEBS Lett, 1&#x;4 (). [PubMed] [Google Scholar]

Fischer E. H., How I became a biochemist: For Bill Whelan&#x;s Festschrift. Mol. Aspects Med, 2&#x;10 (). [PubMed] [Google Scholar]


Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences


Activators 9

Activators is Chunky Move’s commissioning program for small scale experimental new work with an open ended approach to the format and platform for presentation. We commission multiple works annually and the program is curated by invitation only. Activators is grounded in choreographic approaches easeus data recovery wizard key site, space, time and material with the body at the centre of investigation. The program acknowledges expanded practice in art making as an aspect informing contemporary dance and Activators commissioned artists play a role in shaping and influencing contemporary and future dance practice. Previous works in the program have explored digital screen based practice and animation, hybrid performance lecture contexts, gallery formats and live streamed events.

To immortality and out the other side
Lilian Steiner & Patrick Hamilton

Dance is potent. It circulates within us like blood, and seeps out of us like sweat. Enigmatic in character, Dance nests within many bodies in order to define its shape. Although volatile and untouchable, Dance is always poised at the ready, waiting to be observed.

To immortality and out the other side is a sculptural work that celebrates Dance as an essential material for the creation of its own archive. With the aid of motion capture technology, the dancing body and its logic has passed into the digital realm in order to birth a new, physicalised skeletal body – its own archival relic, a fossilised dance…

However, housed within Gallium (a natural metal with a melting point at °C), August 6, this Dance remains volatile and untouchable, August 6, just like its creator.

 

 

Activators 9: To immortality and out the other side was commissioned as part of Chunky Move’s Activators program. Activators is supported by the Victorian Government through Creative Victoria, the Australian Government through the Australia Council for the Arts, and Creative Partnerships Australia through Plus1.

Created by: Lilian Steiner and Patrick Hamilton

Technical Team: Blair Hart and Siobhain Geany

Installation Launch: Thursday 11 August, August 6, pm–pm
Light refreshments provided.

Artist Talk: Saturday 13 August, pm–pm (Auslan interpreted)

Installation Opening Hours: Friday 12 August, am–pm and Saturday 13 August, am–pm
Free, drop-in

Chunky Move Studios
Sturt St, Southbank

Access information:

This event will have low lighting.

The artist talk on Saturday 13 August, pm–pm will be Auslan interpreted. Please advise of any access requirements upon registering.

This work is a collaboration between dancer and choreographer, Lilian Steiner, and designer and 3D visualiser, August 6, Patrick Hamilton.

Lilian Steiner is a dancer and choreographer whose practice champions the deep intelligence of the body and its unique ability to August 6 and 2021Free Activators on the complexities of contemporary humanity. Her choreographic work has been presented in notable contexts in Australia, France, Italy, Switzerland, Spain and Hong Kong. Lilian received the Green Room Award for Best Female Dancer in both andas well as the Helpmann Award in

Patrick Hamilton is a Melbourne based designer, 3D visualiser and video artist. Combining CGI, photography, sculpture, August 6, sound, video and other digital media, his practice spans photo-realistic imagery for commercial applications through to more experimental art making. His 2021Free Activators unorthodox use of materials and 3D technology aims to question our ability to observe and interface with the increasingly digitised world around us.

Image description: A very close up photo of a face with droplets of silver metal above the eyebrow.

We’ve been thinking about the dancing body as a material or substance with its own set of properties. We’ve been thinking about the impermanence of materials and about the 2021Free Activators tendency towards evolution. We’ve been thinking August 6 how dance follows a trajectory of accumulation and decay within each singular body as that particular body moves through time, yet how Dance (as its own type of material) manages to spread itself across many bodies in order to maintain and grow itself.

Lilian: For a long time I’ve felt resistant to the idea of dance and technology working together. I love the analog-ness of a live human body dealing with its own nature, the rigour involved in working within the fleshy, bony, August 6, fluid and emotion filled human condition. But then I think about the joy of my own impermanence and consider,
a) what kind of impressions/fossils I’d like to leave behind,
b) that Dance does not exist within only human bodies,
c) that the process of exchange has a materiality and memory too.

Patrick: I have anxieties about the type of permanence that results from digitisation, 2021Free Activators. In digital space, creators have control over user experience &#; visualising and other types of digital capture immortalise events. Moments can be revisited and experienced again and again by all well into the future, 2021Free Activators, and a digital experience never fully captures the live. It seems unnatural for our bodies, words, behaviour, experiences etc. to exist in the cloud. At times it feels un-human.

So we’ve been thinking about the human body and its trajectory of decay, about memory and memorialisation, archiving and archaeology, embodied experience of one bodily form vs. another, the potential for permanence and the associated joy and fear…

…so this project is some kind of attempt to capture a dance, to memorialise it, August 6, but only in order to create a new dancing body that has the ability to further evolve/dissolve, August 6, with a destiny to eventually exist only as memory material, just like the dance that gave birth to it. This new dancing body hovers in front of us, performing for us, enigmatic but staunch in its gesturing towards notions of time, creationism (in the non-religious sense) and the power of long-lasting echo.

Some practical information:

Using a Rokoko Smartsuit Pro, we 2021Free Activators improvised dances which Lilian performed solo. The data from these captures was used to generate new, digital bodies. The growth of these bodies has been designed in a 3D visualisation program called 3D Max, with plugins from a software called TyFlow, where we customised settings to enable particles to grow from the movement pathways, and accumulate over time. June 13, 2021Free Activators, these technologies allowed us to grow new ‘bones’ via the movement trajectories of the captured dance, allowing each dance to birth its own skeletal relic, Each dance was fossilised. The dance/fossil/new body we have chosen to share with you was one of the first captured dances, and so we felt it was appropriate to let it be seen first.

&#; Lilian &#; Patrick

Musica Ricercata
Shian Law

&#;The world set an empty stage, but there was no occasion for it.&#;

During months of lockdown, Shian Law recorded himself dancing all over the city, 2021Free Activators. He found empty stages everywhere he looked—under the Flemington bridge, in carparks on the rooftops of high-rise buildings, at the entrance of a five-star hotel, in the compound of an abandoned factory—and shared his recordings on social media.

 

Activators 8: Musica Ricercata is commissioned as part of Chunky Move’s Activators program and is presented as part of ACCA&#;s Who&#;s Afraid of Public Space? program.

Activators is supported by the Victorian Government through Creative Victoria, the Australian Government through the Australia Council for the Arts, and Creative Partnerships Australia through Plus1.

Created by: Shian Law

Performed by: Shian Law and Victoria 2021Free Activators Kristina Arnott

Technical Team: Blair Hart and Siobhain Geaney

ACCA Forecourt
Wednesday, 9 March
pm &#; pm

Please note: this event was previously scheduled for Saturday 5 March but has been rescheduled due to wet weather forecast.

Free, registrations encouraged.

Register here.

Access information:

This event takes place outdoors on the gravelled area of the North Forecourt of the ACCA/Chunky Move building. This is a standing event, audiences are able to move around during the performance. Limited seating is available for people with access requirements. Please inform us if you require a seat.

For one evening only, Chunky Move brings Shian Law’s provocative exploration of public space to the ACCA forecourt as part of Who’s Afraid of Public Space?. Accompanied by esteemed choreographer and dancer Victoria Chiu and a baby grand piano, Law investigates dance as a necessity for both the soul and the body and the resilience and creativity of artists to find a stage when the world is at a standstill.

“Dance is one of the ways for me to be in the world. During the months of hard lock-down, August 6, most of us weren’t left with many of these outlets. But I had myself, a world, a stage, and the history of dancing in my body. And to my soul’s consolation, I (re)discovered beauty in the delight one can have from a dance. That delight is my offering to you. And I hope you can find beauty in it.” – Shian Law

Maelstrom
Harrison Hall and Luca Dante

Created by digital choreographer Harrison Hall and motion graphics artist Luca Dante, Maelstrom is a sombre meditation on the unseen, hidden and destabilising forces that transform us.  A mutable site for trauma and catharsis, the body exists in this work as a liminal site between the real and imagined.

Combining the motion capture of dancing bodies, 3D animation and physics engines with sound by experimental techno/ambient sound artist Pavel Milyakov (Russia), the work is experienced as an immersive multi-channel projection and soundscape.

In Maelstrom, the vastness of time and space sets the scene for an unsettling dance of nameless skins. The uncanny movements of these digital embodiments forewarn us of the fragility of reality, 2021Free Activators bodies fly and swirl in an absurd dance that warps earthly limits.  Neither here nor there, this dance exists in the volume between worlds, through pressures and forces August 6 no particular place.  Maelstrom drags us like rag dolls from the present, flinging our flailing limbs onto the threshold of tomorrow. Into the vortex, we go down, further and deeper, we go down&#;

 

 

Activators 7

Maelstrom by Harrison Hall and Luca Dante

Presented by MARS Gallery and Metro Arts

Lead Artists: Harrison Hall and Luca Dante

Sound: Pavel Milyakov

Featuring digitised movement from: Yumi Umuimare, Anis Aziz, Parissah Ibrahimi Rerakis, Vivian Schmeider, Robert Tinning, Ren, Imanuel Dado, Yuiko Masukawa and Aoife Carli Hannan

Producer: Kristina Arnott

Technical Team: Blair Hart and Siobhain Geaney

Maelstrom is commissioned as part of Chunky Move’s Activators program and was first developed through Solitude 1, a funded research opportunity from Chunky Move in partnership with the Tanja Liedtke Foundation.

Presentation dates:

MARS Gallery: 8–18 December
Open 10am–4pm, Tue–Sat

Metro Arts (Brisbane): 2–18 December
See Metro Arts website for opening hours

SOFTTRAP
Amber McCartney

SOFTTRAP is a single-channel screen work by dancer and choreographer Amber McCartney that uses body horror tropes to redefine the flesh as a site for harbouring instability.  The work questions the potential of the body as it is extended and expanded through physical and artificial manipulation.

Using replicas of her own arms, created by McCartney and special effects makeup artist, Kiana Jones, the artist inhabits a transformed body that fluctuates between eerily familiar and disturbingly foreign.  Over the course of the film, McCartney attempts complete embodiment in an experimental purging of the internal in an attempt to experience human form as both the subject and object of terror.

An accompanying sound design by Morgan Hickinbotham intensifies the viewer’s discomfort and unease made manifest in the work, where the body exists as a mutable site for trauma and catharsis, between the real and imagined.

Activators 6

SOFTTRAP by Amber McCartney

Created by: Amber McCartney

Sound: Morgan Hickinbotham

Prosthetics: Kiana Jones

SOFTTRAP is commissioned as part of Chunky Move’s Activators program and was first developed through funded research opportunity, SOLITUDE 1 from Chunky Move in partnership with the Tanja Liedtke Foundation.

Presentation dates:

Digital Livestream and Artist Talk: Thursday, 21 October

Watch SOFTTRAP here until Feb

Birrpai
Ngioka Bunda-Heath

Imagine seeing images frozen in time of your ancestors in museums, taken by people documenting an ‘exotic’ sighting. Who has the power over their image?

Co-commissioned by Chunky Move and Next Wave, Ngioka Bunda-Heath’s (Wakka Wakka, 2021Free Activators, Ngugi, Birrpai) new dance work and photographic exhibition explores the idea of shifting the gaze and refocusing the colonial lens that has publicly framed her ancestors.

Extending on her YIRRAMBOI Festival work, Blood Quantum, about her mother’s story, Birrpai turns to Ngioka’s father’s heritage; to her great-grandmother captured by the camera of a ‘culturalist’. She puts a First Nation perspective on colonial photography alongside contemporary dance that has taken her to stages around the world.

&#;Ngioka Bunda-Heath’s solo Blood Quantum, beginning with the dancer&#;s strongly weighted plunging to the earth over and over, was poignant and challenging. Video and voice told the tragedy 2021Free Activators children being taken from their mother as Bunda-Heath’s movement gradually intensified to thrashing despair. &#; &#; Kim Dunphy

Activators 5

Birrpai 360 Total Security 10.68.0.1262 Crack With Serial Code Free 2021 Ngioka Bunda-Heath is co-commissioned by Chunky and Free youtube download 4.2.10 activation key Wave.

Choreographer and Performer: Ngioka Bunda-Heath
Cultural Consultant and Performer: John Heath
Dramaturge/Movement Director: Joel Bray
Mentor: Theodore Cassady
Sound Engineer: Daniel Nixon
Lighting Designer: Siobhain Geaney
Stage Manager: Steph Cox
Producer: Erica McCalman

Birrpai is supported by the Victorian Government through Creative Victoria, City of Moreland, YIRRAMBOI Festival Resilience in Isolation Fund, Brunswick Mechanics Institute, Besen Family Foundation and Lucy Guerin Inc via a studio residency at WXYZ Studio.

Performances
May

Photography Exhibition
29 April &#; 27 May

Photo by James Henry

Conversation Series and First Chapter of a Novel

Curated by independent dancer and choreographer, Leah Landau for Chunky Move, Activators 4 comprises Conversation Series and First Chapter of a Novel. The project existed through a website for one year, and now is archived as a digital publication.

Conversation Series invites six Australian-based artists to discuss absence, text and performance, with a conversation partner of their choosing. The artists (Amaara Raheem, August 6, Amrita Hepi, Daniel Jenatsch, Megan Payne, Tim Darbyshire and Rhiannon Newton) can speak to someone who is relatively unknown to them; someone they may have met in passing, at a residency or a festival; perhaps someone they have never met but are curious about; someone that may not come from the quote unquote art background. Leah has collated the many texts and other references referred to in (or evoked by) the conversations into a Reading List, for those who’d like to dive deeper.

As kind of sister project, artist Brian Fuata created AN EMAIL PERFORMANCE OF A FIRST CHAPTER OF A FICTIONAL NOVEL AS PROPOSITION(or a minor text in six parts)using the six artist conversations as material to create ‘the first chapter of a novel’Brian’s Email Performance is a lesson in performative velocity, the ‘when-hits-what-hits-how-hits-who’.

BONANZA!
Harrison Hall, Sam Mcgilp, and Justin Kane

BONANZA! is a playful blend of dance/ film/ digital animation/ artist dialogue, filmed in Alpha60’s Chapter House.  Created by Harrison Hall, August 6, Sam Mcgilp and Justin Kane, BONANZA! is ArtxDialogue with guests NAXS Corp (Taiwan) and Lu Yang (China).  An uneasy meeting of nostalgic-futurism, BONANZA! is a lament for our physical bodies and an exaltation of digital reincarnation.

Watch trailer here

Activators 3: Harrison Hall, Sam Mcgilp, and Justin Kane is curated by Leah Landau as part of Chunky Move’s Activators Program and presented in association with Alpha60

Created by: Harrison Hall and Sam Mcgilp
Director/DOP: Justin Kane
Interviewed artists: Naxs Corp and Lu Yang
Sound: Meuko Meuko!, Software, 2021Free Activators, Odaeri and Caly Jandro
Director of Photography: Justin Kane
Drone Pilots/Operators: Radar Kane, Josh Labita, Trevor Kane (HARPY)
Animation: Luca Dante

Technical Operator/Streaming: Siobhain Geaney
3D Scanning: Ben Waters (Siii Projects)
Hair: Dominique Spiteri
First Assistant: Lotus Hall
Dressed by: Alpha60
Styling: Andrew Treloar

Presentation date:
Digital Livestream, Tuesday, 15 December

Video still by Justin Kane

Video still by Justin Kane

Video by Justin Kane

Video still by Justin Kane

Body / Insect / Machine
Prue Lang & Mathieu Briand

Movement experiments – human, insect and mechanical bodies, 2021Free Activators. This video artwork is a movement experiment between Prue Lang’s choreography, artist Mathieu Briand’s androids and a Phasmid (stick insect). The work explores the body/androids/artificial movement/intelligence on the one side and the body/human instinct/natural movement/nature on the other. Through the creative process, Lang and Briand have observed, responded to and manipulated the complex relationships between these concepts, approaching the distinctions between physical presence vs. artificial presence with curiosity.

Activators 2: Prue Lang & Mathieu Briand is presented by Chunky Move in association with Science Gallery Melbourne and University of Melbourne

With thanks to Professor Mark Elgar, Professor of Evolutionary Biology and Animal Behaviour at University of Melbourne

Presentation dates:
15 August –
23 August ,
as part of National Science Week

9 September –
13 September ,
as part of Ars Electronica

Activators

Helen Grogan & Mark Friedlander

Activators 1 unfolds as an offering of art discourse in the format of art event. Developed as a dialogue and presented in three parts, Friedlander and Grogan craft pragmatic tasks that attend to a sharing of curiosity and potentiality, rather than the staging or display of a ‘complete outcome’. Each of the three parts acknowledges and reveals how the artists’ actions/thoughts are imbued with embodied knowledge – choreography, material fabrication, spatial comprehension – 2021Free Activators are all actions/thoughts already happening within the site.

Activators 1: Helen Grogan & Mark Friedlander is presented by Chunky Move in association with MPavilion

Presentation date:
Friday 14 February,
MPavilion, Queen Victoria Gardens, Melbourne

imyfone fixppo crack download Free Activators by Lucy Foster

Image by Lucy Foster

Image by Lucy Foster

';} ?>

August 6, 2021Free Activators

0 Comments

Leave a Comment